chitosan has been researched along with folic acid in 224 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (4.46) | 29.6817 |
| 2010's | 141 (62.95) | 24.3611 |
| 2020's | 73 (32.59) | 2.80 |
| Authors | Studies |
|---|---|
| Kawashima, S; Kontani, Y; Murata, Y; Ohmae, H | 1 |
| Dittrich, M; Kladnícková, I; Klein, T; Martinac, A | 1 |
| Beaumont, E; Benderdour, M; Cuie, Y; Fernandes, JC; Lavigne, P; Mansouri, S; Shi, Q; Winnik, F | 1 |
| Chan, P; Chung, JE; Kurisawa, M; Yang, YY | 1 |
| Benderdour, M; Dai, K; Fernandes, JC; Jreyssaty, C; Lavigne, P; Qiu, X; Shi, Q; Wang, H; Winnik, FM; Zhang, X | 1 |
| Li, H; Sun, Y; Wan, A | 1 |
| Cao, MM; Gong, JL; Hu, XG; Wang, SM; Zhang, JR | 1 |
| Bi, Y; Cai, Z; Chen, Q; Hou, S; Li, Y; Song, X; Zheng, Y | 1 |
| Arote, R; Cho, CS; Cho, MH; Jere, D; Jiang, HL; Kim, YK; Lim, HT; Xu, CX | 1 |
| Bi, Y; Cai, Z; Chen, Q; Hou, S; Song, X; Xu, J; Yu, B; Zhao, D; Zheng, Y | 1 |
| Bi, Y; Cai, Z; Chen, Q; Darby, M; He, L; Hou, S; Lee, RJ; Li, Y; Liang, Y; Song, X; Sun, Y; Xu, J; Yang, X; Zheng, Y | 1 |
| Ghosh, SK; Maiti, TK; Mallick, SK; Pramanik, P; Sahu, SK; Santra, S | 1 |
| Morris, VB; Sharma, CP | 2 |
| Chang, J; Gong, X; Liang, X; Niu, R; Song, T; Wang, H; Zhao, P | 1 |
| Lin, FH; Shieh, MJ; Tsai, HM; Tsai, KC; Wei, MF; Wong, JM; Yang, SJ | 1 |
| Gao, C; Ma, L; Moya, S; Rojas, E; Romero, G; Zhou, J | 1 |
| Ghosh, SK; Maiti, S; Maiti, TK; Pramanik, P; Sahu, SK | 2 |
| Cheng, C; Fan, L; Gu, CH; Li, F; Li, X; Wang, Y; Wu, H; Yang, Q; Zhang, H; Zhang, S | 1 |
| Cao, S; Chang, J; Niu, R; Wang, H; Yu, M; Zhang, F; Zhao, P | 1 |
| Kim, S; Lee, J | 1 |
| Hwang, T; Kang, E; Kim, JH; Kwon, OJ; Lee, JM; Park, H; Park, Y; Yun, CO | 1 |
| Chen, Z; Deng, F; Fan, C; Fan, H; Gao, W; Li, M | 1 |
| Chin, HC; Lin, CF; Lin, FH; Shieh, MJ; Tsai, HM; Wong, JM; Yang, SJ | 1 |
| Benderdour, M; Dai, K; Fernandes, JC; Qiu, X; Shi, Q; Tran, C; Wang, H; Winnik, FM; Zhang, X | 1 |
| Chen, L; Kong, LX; Li, P; Peng, Z; Wang, Y; Zeng, F | 1 |
| Liu, CG; Tan, YL | 1 |
| Huang, H; Misra, RD; Shah, JS; Yuan, Q | 1 |
| Kang, E; Kim, JH; Kwon, OJ; Park, HK; Park, Y; Yun, CO | 1 |
| Beninati, S; Desideri, A; Galbiati, A; Mattioli, P; Morozzo Della Rocca, B; Paradossi, G; Tabolacci, C | 1 |
| Cai, LL; Chen, FY; Du, YZ; Hu, FQ; Li, J; Yuan, H; Zhao, MD | 1 |
| Chen, Y; Duan, C; Hao, L; Jia, L; Liu, G; Liu, Y; Wang, F; Zhang, D; Zhang, Q; Zheng, D | 2 |
| Feng, S; Guo, W; Guo, Z; Jing, H; Yang, W; Zhang, X | 1 |
| Chen, ZL; Fan, CX; Gao, WH; Liu, ST; Qi, LY | 1 |
| Meng, L; Zhao, Q; Zhao, X; Zu, S; Zu, Y | 1 |
| Chang, J; Han, J; Ji, W; Liao, Z; Niu, R; Wang, H; Wang, X; Wu, B; Yu, M; Zhang, F; Zhang, H; Zhao, P | 1 |
| Cheng, T; Guan, XM; Lan, JF; Liu, XY; Shen, JM; Zhang, HX | 1 |
| Guo, W; Guo, Z; Jing, H; Xu, P; Yang, W; Zhang, X | 1 |
| Fei, XN; Li, C; Liu, Y | 1 |
| Chakraborty, SP; Pramanik, P; Roy, S; Sahu, SK | 2 |
| Guo, H; Guo, S; Hao, L; Li, C; Wang, F; Zhang, D; Zhang, Q; Zheng, D | 1 |
| Benderdour, M; Dai, K; Fernandes, JC; Qiu, X; Shi, Q; Winnik, FM; Zhang, X | 1 |
| Lin, H; Qu, D; Xue, J; Zhang, C; Zhang, N | 1 |
| Bodnár, M; Borbély, J; Hajdu, I; Kollár, J; Márián, T; Trencsényi, G; Vámosi, G | 1 |
| Chen, D; Jiang, F; Meng, X; Shu, C; Song, P; Sui, W; Wan, LJ | 1 |
| Agostinelli, E; Chamundeeswari, M; Lakhsmi, BS; Sastry, TP; Senthil, V | 1 |
| Cao, J; Cui, S; Gu, Y; Qian, Z; Zhu, H | 1 |
| Cai, X; Du, H; Zhai, G | 1 |
| Du, P; Liu, P; Mu, B; Zeng, J | 1 |
| Choi, JW; Kang, E; Kim, SW; Kwon, OJ; Yun, CO | 1 |
| Che, X; Liu, P; Liu, Y; Lu, L; Wu, J; Xie, X; Xu, X; Yu, H; Yu, J | 1 |
| Chakraborty, SP; Mahapatra, SK; Pramanik, P; Roy, S; Sahu, SK | 1 |
| Cho, CS; Cho, MH; Jiang, HL; Kim, YK; Lee, JH; Minai-Tehrani, A | 1 |
| Wang, J; Xu, Q; Xu, S; Zhang, L; Zhang, N; Zhou, J | 1 |
| Liu, X; Ma, D; Tan, L; Tang, H; Xie, Q; Yao, S; Zhang, Y | 1 |
| Kuo, ML; Lin, CF; Tan, CT; Yang, SJ | 1 |
| Karmakar, P; Laha, D; Pramanik, A; Pramanik, P | 1 |
| Chen, D; Cheng, L; Guan, G; Hu, H; Qiao, M; Qiu, L; Sun, Y; Wang, M; Zhang, J; Zhao, X | 1 |
| Honke, K; Li, TS; Yawata, T | 1 |
| Tang, C; Yin, C; Zhang, S | 1 |
| Chen, Z; Cui, W; Liu, L; Song, H; Su, C; Zhao, L; Zhu, B | 1 |
| Iturbe, LC; Katime, I; Pérez-Álvarez, L; Pujana, MA | 1 |
| Astilean, S; Baldeck, P; Boca-Farcau, S; Juhem, A; Potara, M; Simon, T | 1 |
| Guo, R; Li, W; Shi, Z; Tang, Y; Xue, W; Zhang, Y | 1 |
| Bánfalvi, G; Bodnár, M; Borbély, J; Emri, M; Hajdu, I; Kollár, J; Márián, T; Sikula, J; Trencsényi, G; Vámosi, G | 1 |
| Gao, QH; He, YX; Li, HL; Wu, GZ | 1 |
| Chen, L; Li, L; Liu, Y; Wang, J; Yan, X; Zhang, W | 1 |
| Tang, C; Yin, C; Yu, B | 1 |
| Battogtokh, G; Kang, JH; Ko, YT | 1 |
| Kwag, DS; Lee, ES; Oh, KT | 1 |
| Bi, J; Dai, S; Shi, B; Zhang, H | 1 |
| Correia, IJ; Costa, EC; Gaspar, VM; Pichon, C; Queiroz, JA; Sousa, F | 1 |
| Emami, J; Hasanzadeh, F; Lavasanifar, A; Minaiyan, M; Mostafavi, A; Rezazadeh, M; Rostami, M; Sadeghi, H | 1 |
| Kong, L; Li, P; Li, S; Peng, Z; Wang, Q; Wang, Y; Yang, Z | 1 |
| Choi, KC; Choi, SH; Kim, DH; Lee, HY; Lee, KD | 1 |
| Gu, JW; Guo, YZ; Hou, DP; Jing, HY; Katsumi, H; Sakane, T; Wang, J; Yamamoto, A; Yan, CY | 1 |
| Cho, CS; Cui, PF; Jiang, HL; Xie, RL | 1 |
| Hu, J; Li, J; Shen, A; Zhang, G | 1 |
| Baigude, H; Gao, X; Hai, X; Li, Z; Shen, B; Su, H; Tan, Z; Yu, S; Zhang, R | 1 |
| Bin, J; Chen, Y; Deng, YL; Jiang, G; Le, DE; Li, M; Liao, Y; Lin, ZT; Liu, Y; Wang, H; Xiao, Y | 1 |
| Chen, DF; Duan, S; Li, RQ; Song, HQ; Xu, FJ; Yu, B; Zhao, H | 1 |
| Correia, A; Gama, FM; Jones, AT; Pedrosa, SS; Pereira, P; Sayers, E; Vilanova, M; Wymant, JM | 1 |
| Chen, HP; Chen, MH; Liu, TY; Tung, FI | 2 |
| He, J; Lai, C; Lu, X; Luo, G; Peng, Y; Xie, X; Xie, Y; Yu, X; Zhao, Y; Zhou, N; Zhou, S; Zhuo, H | 1 |
| Atyabi, F; Jalilian, AR; Johari-Daha, F; Mollarazi, E | 1 |
| Lai, WF; Lin, MC | 1 |
| Gao, Q; Hua, D; Huang, C; Wang, F; Yang, S; Yuan, J | 1 |
| Cao, Y; Dong, J; Jiang, B; Liu, M; Lu, B; Pei, R; Tong, X; Zhang, H; Zhang, K; Zheng, H | 1 |
| Firuzi, O; Hamidi, M; Miri, R; Mohammadi-Samani, S; Rostamizadeh, K; Sadighian, S; Zarrin, A | 1 |
| Dorkoosh, FA; Ghaffarzadegan, R; Ghazizadeh, L; Mirzakhanlouei, S; Naghibi Beidokhti, HR | 1 |
| Duan, S; He, J; Huang, X; Huang, Y; Lai, C; Lu, X; Meng, J; Qian, Z; Su, J; Yu, X; Zhang, Z; Zhao, Y; Zhou, N; Zhou, S | 1 |
| Duan, S; Fang, Y; He, J; Huang, X; Lai, C; Lu, X; Luo, G; Song, M; Xie, Y; Yi, P; Yu, X; Zhang, Z; Zhao, J; Zhao, Y; Zhou, N; Zhou, S | 1 |
| Elbarbary, AM; Hatab, MH; Ibrahim, IA; Othman, SH | 1 |
| Bai, H; Cai, J; Chen, ZW; Huang, L; Jiang, J; Jin, H; Li, L; Li, T; Pi, J; Shao, M; Wang, X; Yang, F; Yang, P; Zhu, H | 1 |
| Afzal, M; Alamgir, K; Bano, S; Nazir, S; Waraich, MM | 1 |
| Bahadur, D; Sasidharan, S; Shanavas, A; Srivastava, R | 1 |
| Tang, C; Wu, J; Yin, C | 1 |
| Ekgasit, S; Komenek, S; Luesakul, U; Muangsin, N; Praphairaksit, N; Puthong, S; Vilaivan, T | 1 |
| Baigude, H; Gao, X; Guan, W; Hai, X; Liu, Z | 1 |
| Cao, Y; Ma, Q; Wang, F; Wang, Y; Yu, B | 1 |
| Cheng, LC; Jiang, Y; Lu, HY; Qiu, LL; Xie, Y; Yang, Q | 1 |
| He, R; Yin, C | 1 |
| Haque, P; Islam, MS; Khan, M; Khan, MN; Mallik, AK; Rahman, MM; Rashid, TU | 1 |
| Amanpour, S; Bagheri-Khoulenjani, S; Esfandiarpour-Boroujeni, S; Mirzadeh, H | 1 |
| Cui, X; Feng, Y; Li, Z; Liu, Y; Shi, C; Wang, G; Zhang, H; Zhong, S | 1 |
| Gu, J; Jing, H; Lee, RJ; Taishi, J; Yan, C | 1 |
| Bharti, S; Koch, B; Muthu, MS; Pandey, BL; Sharma, G; Singh, RP; Singh, S | 1 |
| Cheng, L; Fan, Q; Hao, T; Li, D; Lv, H; Ma, H; Peng, J; Shao, M; Zhao, C; Zong, X | 1 |
| Chen, H; Gao, Y; Li, Z; Lv, T; Xie, X; Zhang, H; Zhang, Y | 1 |
| Chen, J; Duan, S; He, J; Hu, Z; Lu, X; Su, J; Yang, N; Zhang, Z; Zhao, Y; Zhou, S | 1 |
| Chen, S; Chen, X; Chi, T; Fan, L; Jia, L; Jiang, K; Li, T; Liu, Y; Shao, J; Zheng, G | 1 |
| Chanphai, P; Tajmir-Riahi, HA | 2 |
| Antoniraj, MG; Ayyavu, M; Henry, LJK; Kandasamy, R; Nageshwar Rao, G; Natesan, S; Sundar, DS | 1 |
| Han, MK; Liu, D; Merlin, D; Wang, L; Xu, C; Zhang, M | 1 |
| Deb, A; R, V | 1 |
| A, S; Ayyavu, M; Kandasamy, R; M, GA; S, AT | 1 |
| Cao, J; Wang, W; Wu, J; Wu, Q; Wu, Y; Yuan, Z; Zhang, Y | 1 |
| Chen, H; Hu, Y; Ke, L; Xiao, X; Yang, X; Zeng, S; Zhao, D; Zhuo, M | 1 |
| Luesakul, U; Muangsin, N; Neamati, N; Puthong, S | 1 |
| Amighi, K; Gelbcke, M; Hecq, J; Mathieu, V; Mathivet, T; Rosière, R; Van Antwerpen, P; Van Woensel, M; Vermeersch, M; Wauthoz, N | 1 |
| Chen, CC; Chen, XA; Chen, YC; Cheng, KM; Hong, PD; Tsai, TN; Yen, HJ; Young, JJ; Young, YA | 1 |
| Bothiraja, C; Panda, B; Pawar, A; Poudel, I; Rajalakshmi, S; Rajput, N | 1 |
| Benabdoune, HA; Benderdour, M; Dai, K; Dalla Picola, IP; Fernandes, JC; Rondon-Cavanzo, EP; Shi, Q; Tiera, MJ; Zhang, X | 1 |
| Akinyelu, J; Singh, M | 1 |
| Huang, LL; Li, D; Pang, JD; Sun, K; Wang, F; Wang, LT; Wang, R; Zhang, LM | 1 |
| Chanphai, P; Tajmir-Riahi, HA; Thomas, TJ | 1 |
| Bidaki, K; Mohammadnejad, J; Narmani, A; Rezvani, M | 1 |
| Jiao, Z; Mei, Y; Wang, X; Xia, J; Yin, Y | 1 |
| Gan, Y; Gu, Y; Liu, Y; Qiu, N; Zhang, S; Zhu, H | 1 |
| Nawaz, A; Wong, TW | 1 |
| Dahiru, NS; Dramou, P; Fizir, M; He, H; Itatahine, A; Mehdi, YA; Taleb, A; Wei, L; Zhang, J | 1 |
| Jia, C; Ren, T; Sun, H; Tan, X; Yang, Z; Zhang, Y | 1 |
| Cui, F; Kawashima, Y; Li, L; Liang, N; Sun, S; Wang, D; Yan, P | 1 |
| Hatami, M; Mallakpour, S | 1 |
| Chen, Z; Li, Y; Lin, Y; Liufu, C; Tu, J; Yang, C | 1 |
| Dai, Y; Gai, S; He, F; Li, W; Liu, S; Suh, YD; Yang, G; Yang, P; Zhong, C | 1 |
| Li, B; Li, H; Li, Y; Liang, C; Sun, X; Wang, H | 1 |
| Amanlou, M; Bigdeli, B; Dehghani, S; Goliaei, B; Hosseini, M; Khoobi, M; Lotfabadi, A; Naeimi, H; Nejadshafiee, V; Nezamtaheri, MS; Sadighi, A; Sharifzadeh, M | 1 |
| Jain, A; Jain, R; Jain, S; Khatik, R; Veer Kohli, D | 1 |
| Bodnár, M; Borbély, J; Garai, I; Hajdu, I; Kerekes, K; Kertész, I; Kollár, J; Körhegyi, Z; Kun, S; Rózsa, D; Trencsényi, G; Varga, J | 1 |
| Chen, H; Li, W; Tao, R; Wang, C; Ye, J; Zhang, C; Zhou, H | 1 |
| Chen, Z; Geng, P; Jiang, R; Li, M; Li, X; Song, C; Wang, Z; Yin, S; Yu, N; Yu, W | 1 |
| Öztürk, AA; Şenel, B | 1 |
| Adeyemi, SA; Choonara, YE; du Toit, LC; Kondiah, PPD; Kumar, P; Marimuthu, T; Pillay, V | 1 |
| Abdel-Bar, HM; Ali, RA; El Leithy, ES | 1 |
| Chen, D; Hu, H; Ji, H; Li, J; Zhao, M | 1 |
| Jun, SW; Kang, YH; Kim, CS; Kwon, J; Lee, J; Ly, CD; Manivasagan, P; Mondal, S; Nguyen, VT; Oh, J | 1 |
| Guo, S; Huang, W; Jin, Z; Liu, Q; Sheng, Y; Wang, Z | 1 |
| Cheng, L; Li, J; Liu, C; Liu, Y; Lu, H; Wang, D; Wei, J; Xu, B; Yin, S | 1 |
| Askari, A; Banihashem, S; Chogan, F; Davaran, S; Farboudi, A; Irani, M; Karimi, M; Mahboobnia, K | 1 |
| Akbari, A; Mohammadzadeh, R; Shahim, P | 1 |
| Chen, J; Dou, Y; Tang, Y; Zhang, X | 1 |
| Li, X; Liu, Z; Wang, J; Xu, Y; Yang, Y; Zhang, Y; Zhao, Z | 1 |
| Jang, EH; Kang, H; Kim, GL; Kim, JH; Kim, S; Shim, MK | 1 |
| Chen, Y; Huang, S; Lee, I; Xuan, G; Zhang, M | 1 |
| Kaul, A; Kumar, V; Leekha, A; Mishra, AK; Verma, AK | 1 |
| Jayasree, RS; Jibin, K; Maiti, KK; Prasad, JS; Saranya, G; Shenoy, SJ | 1 |
| Attia, SA; Filipczak, N; Khan, MM; Madni, A; Pan, J; Rai, N; Rehman, M; Torchilin, VP | 1 |
| Kumar, P; Musalli, AH; Roy, P; Talukdar, PD; Wong, TW | 1 |
| Dusane, AC; Indukuri, VV; Janardhanam, LSL; Venuganti, VVK; Verma, P | 1 |
| He, DX; Huang, C; Huang, W; Liu, Y; Long, J; Tan, XW; Tang, S; Wei, H; Xiang, Y; Yu, CY; Zhou, Y | 1 |
| Bai, H; Huang, G; Liu, L; Tang, G | 1 |
| Musa, N; Wong, TW | 1 |
| Benabdoun, HA; Benderdour, M; Fernandes, JC; Rondon, EP; Segalla Petrônio, M; Tiera, MJ; Vallières, F | 1 |
| Jia, L; Li, Z; Zhao, Z; Zheng, D | 1 |
| Cui, Y; Hu, X; Kuang, W; Li, C; Ling, X; Ren, J; Sun, X; Yan, Y; Zou, J | 1 |
| Cheng, H; Cui, Z; Guan, J; Guo, S; Huo, Y; Mao, S; Zhang, X | 1 |
| Afzali, E; Ansari, M; Eslaminejad, T; Shahrokhi-Farjah, M; Yazdi Rouholamini, SE | 1 |
| Bhattacharyya, S; Horo, H; Kundu, LM; Mandal, B | 1 |
| Zewail, M | 1 |
| Agudelo, NA; Echeverri-Cuartas, CE; Gartner, C | 1 |
| Astilean, S; Focsan, M; Licarete, E; Nagy-Simon, T; Potara, M; Soritau, O; Vulpoi, A | 1 |
| Hanafy, NAN | 1 |
| Hu, Q; Khan, MA; Liang, L; Luo, Y; Wang, T; Xue, J | 1 |
| Faninam, F; Hashemi, M; Kazemi, NM; Khaleghi, S; Mokri, N; Sepehri, Z | 1 |
| Chen, J; Du, Q; Huang, J; Lv, F; Tang, X; Zhao, Z | 1 |
| Babu, D; Gautam, M; Karuppaiah, A; Natrajan, T; Nesamony, J; Rajan, R; Ranganathan, H; Sankar, V; Selvaraj, D; Siram, K | 1 |
| Dai, S; Hu, F; Liu, Y; Meng, T; Qiu, G; Wen, L; Yu, F; Yuan, H; Zhou, X; Zhu, Y | 1 |
| Meshkini, A; Rafie, M | 1 |
| Mendoza-Guevara, CC; Ramon-Gallegos, E; Ramos-Godinez, MDP; Trejo-Santillan, I | 2 |
| Dao, TP; Doan, P; Doan, VD; Nguyen, BT; Nguyen, DT; Nguyen, VT; Plavskii, V; Tran, NQ | 1 |
| Al-Nemrawi, NK; Altawabeyeh, RM; Darweesh, RS | 1 |
| Bani, F; Gao, H; Kahroba, H; Nemati, M; Rahbarghazi, R; Rasmi, Y; Sadeghi, MR; Sepasi, T; Wang, Y; Zamiri, RE; Zarebkohan, A | 1 |
| Abdouss, M; Hosseini, SM; Mazinani, S; Soltanabadi, A | 1 |
| Aboushoushah, SF; Elbialy, NS; Mohamed, N | 1 |
| Bhaskaran Sathyabhama, A; Geethakumari, D; Mohandas, D; Raji Sathyan, K; Somasekharan, JV; Thavarool Puthiyedathu, S | 1 |
| Jang, ES; Jeong, MS; Manivasagan, P; Saravanakumar, K; Sathiyaseelan, A; Wang, MH | 1 |
| Homayouni Tabrizi, M; Karimi, E; Rahmati, A; Zarei, B | 1 |
| Anand, T; Fathima, E; Khanum, F; Naika, M; Nallamuthu, I | 1 |
| Bazylińska, U; Caltagirone, C; Fornasier, M; Handschin, S; Kulbacka, J; Manni, LS; Mezzenga, R; Murgia, S; Picci, G; Wawrzyńczyk, D | 1 |
| Ghahremani, F; Hosseini, M; Jolfaie, NA; Kefayat, A; Rafienia, M | 1 |
| Abdelnaby, E; Ezzat, AA; Hanafi, RS; Magdeldin, S; Mansour, S; Osama, A; Rashad, O; Tammam, SN | 1 |
| Li, Q; Lv, X; Tang, C; Yin, C | 1 |
| Kim, YJ; Lee, YJ; Park, Y | 1 |
| Anbalagan, M; Gor, R; Kesavan, Y; Lazer, LM; Narayan, S; Pathak, S; Ramachandran, I; Ramalingam, S | 1 |
| Alhajamee, M; Homayouni Tabrizi, M; Khademi, D; Sadeghzadeh, F; Torshizi, GH; Ziaratnia, AS | 1 |
| Chen, J; Chen, X; Ge, Y; Huang, K; Lin, Z; Lv, Z; Pan, Y; Sun, X; Yao, Q; Yu, H | 1 |
| Chen, Q; Deng, R; Gui, S; Guo, Y; Jin, X; Lu, X; Su, L; Wang, J; Wang, S; Wang, Z; Xin, H; Xu, Y; Zeng, J; Zhang, L; Zhu, B | 1 |
| Behera, C; Kumari, P; Mahto, SK; Mehata, AK; Muthu, MS; Suseela, MNL | 1 |
| Chourasia, MK; Kumar, A; Maurya, P; Mishra, N; Nisha, R; Pal, RR; Saklani, R; Saraf, SA; Singh, P; Singh, S | 1 |
| Ali, A; Basit, A; Jan, N; Khan, MM; Khan, S; Madni, A; Rai, N; Shafiq, A; Shah, H | 1 |
| Adibfar, S; Gholizadeh Navashenaq, J; Hassannia, H; Hojjat-Farsangi, M; Izadi, S; Jadidi-Niaragh, F; Karpisheh, V; Masjedi, A; Mohammadi, H; Nazer, A; Rashidi, B; Tarokhian, H | 1 |
| Akhbari, K; Parsaei, M | 1 |
| Choudhury, AR; Srivastava, N | 1 |
| Li, Z; Liang, N; Sun, S; Yan, P; Zhao, W | 1 |
| Bi, Y; Chen, W; Ding, Z; Jiang, F; Kong, F; Mo, M | 1 |
| Amiri, H; Hashemy, SI; Hosseini, H; Jaseem, MMM; Sadeghzadeh, F; Tabrizi, MH | 1 |
| Karimi, S; Namazi, H | 1 |
| Faramarzi, M; Panahi, M; Rahbari-Sisakht, M | 1 |
| Chen, J; Liu, D; Pan, H; Pan, W; Su, Y | 1 |
| Barati Naeeni, N; Ghafaripour, H; Homayouni Tabrizi, M; Karimi, E | 1 |
| Amirishoar, M; Ganji, S; Jafari, SM; Jahedi, R; Kharazmi, MS; Narmani, A | 1 |
| Ghahremanloo, A; Ghoreyshi, N; Hashemy, SI; Homayouni Tabrizi, M; Javid, H | 1 |
| Alyasiri, FJ; Ghobeh, M; Tabrizi, MH | 1 |
| Bhaskar, KV; Bhaskaran, NA; Birangal, SR; Gourishetti, K; Hari, G; Jitta, SR; Kulkarni, OP; Kumar, L; Sharma, P; Verma, R | 1 |
| Es-Haghi, A; Homayouni Tabrizi, M; Mollaei, M | 1 |
| Ding, H; Du, Q; Ping, H; Wang, K; Wu, M; Yang, Z; Zhang, M | 1 |
| Gaber, M; Ghareeb, D; Hamed, A; Hamed, M; Mohamed, TM; Nofal, MS | 1 |
2 review(s) available for chitosan and folic acid
| Article | Year |
|---|---|
Advances in the targeting molecules modified chitosan-based nanoformulations.
Topics: Antibodies; Carbohydrates; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Folic Acid; Humans; Nanocapsules; Peptides; Pharmaceutical Preparations | 2013 |
Chemical modification of chitosan for efficient gene therapy.
Topics: Amino Acids; Animals; Blood-Brain Barrier; Chitosan; Folic Acid; Galactose; Genetic Therapy; Genetic Vectors; Humans; Hyaluronic Acid; Hydrogen-Ion Concentration; Ligands; Magnetics; Mannose; Sulfhydryl Compounds; Transfection | 2014 |
222 other study(ies) available for chitosan and folic acid
| Article | Year |
|---|---|
Behavior of alginate gel beads containing chitosan salt prepared with water-soluble vitamins.
Topics: Alginates; Bile Acids and Salts; Biocompatible Materials; Chemistry, Pharmaceutical; Chitin; Chitosan; Citric Acid; Folic Acid; Glucuronic Acid; Hexuronic Acids; Hydrogel, Polyethylene Glycol Dimethacrylate; Microspheres; Orotic Acid; Solubility; Vitamins | 2002 |
[Liberation of folic acids from composite chitosan films].
Topics: Biocompatible Materials; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Chitosan; Folic Acid | 2004 |
Characterization of folate-chitosan-DNA nanoparticles for gene therapy.
Topics: Cells, Cultured; Chitosan; DNA; Folic Acid; Genetic Therapy; Humans; Nanostructures; Particle Size; Transfection | 2006 |
Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery.
Topics: Carrier Proteins; Chitosan; DNA; Drug Carriers; Folate Receptors, GPI-Anchored; Folic Acid; Gene Transfer Techniques; Genetic Vectors; Humans; Hydrogen-Ion Concentration; Models, Chemical; Neoplasms; Plasmids; Polyethylene Glycols; Receptors, Cell Surface; Solubility; Water | 2007 |
Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Arthritis, Experimental; Bone and Bones; Chitosan; Dinoprostone; DNA; Folic Acid; Gene Transfer Techniques; Genetic Therapy; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Isoenzymes; Nanoparticles; Osteoblasts; Rats; Tartrate-Resistant Acid Phosphatase; Tumor Necrosis Factor-alpha | 2008 |
Characterization of folate-graft-chitosan as a scaffold for nitric oxide release.
Topics: Animals; Chitosan; Folic Acid; Humans; Nitric Oxide; Nitric Oxide Donors; Penaeidae; Spectroscopy, Fourier Transform Infrared; Tissue Scaffolds; Transplants | 2008 |
[Synthesis and characterization of folic acid-conjugated chitosan nanoparticles as a tumor-targeted drug carrier].
Topics: Antineoplastic Agents; Chitosan; Drug Carriers; Drug Compounding; Folic Acid; HeLa Cells; Humans; Nanoparticles | 2008 |
Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.
Topics: Animals; Carrier Proteins; Cattle; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Endocytosis; Fluorescein-5-isothiocyanate; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Particle Size; Receptors, Cell Surface; Serum Albumin, Bovine; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis | 2009 |
The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.
Topics: Administration, Inhalation; Aerosols; Animals; Chitosan; Drug Carriers; Folic Acid; Gene Silencing; Gene Targeting; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Polyethyleneimine; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Treatment Outcome | 2009 |
Receptor mediated gene delivery by folate conjugated N-trimethyl chitosan in vitro.
Topics: Alginates; Animals; Biological Transport; Carrier Proteins; Cell Survival; Chitosan; Cross-Linking Reagents; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Endocytosis; Female; Folate Receptors, GPI-Anchored; Folic Acid; Glucuronic Acid; Hexuronic Acids; Humans; Inhibitory Concentration 50; KB Cells; Mice; Microscopy, Atomic Force; Microscopy, Confocal; Nanoparticles; NIH 3T3 Cells; Nucleic Acid Conformation; Plasmids; Receptors, Cell Surface; Time Factors; Transfection | 2009 |
Preparation and characterization of folate-poly(ethylene glycol)-grafted-trimethylchitosan for intracellular transport of protein through folate receptor-mediated endocytosis.
Topics: Carrier Proteins; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Endocytosis; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Immunoblotting; Microscopy, Fluorescence; Particle Size; Polyethylene Glycols; Polymers; Protein Transport; Receptors, Cell Surface | 2010 |
In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery.
Topics: Chitosan; Doxorubicin; Drug Carriers; Flow Cytometry; Folic Acid; HeLa Cells; Hematinics; Humans; Microscopy, Electron, Transmission; Nanoparticles; Oxides; Spectroscopy, Fourier Transform Infrared | 2010 |
Folate mediated histidine derivative of quaternised chitosan as a gene delivery vector.
Topics: Animals; Carrier Proteins; Cattle; Cell Line, Tumor; Chitosan; DNA; Folate Receptors, GPI-Anchored; Folic Acid; Gene Targeting; Gene Transfer Techniques; Genetic Vectors; Histidine; Humans; Microscopy, Electron, Transmission; Molecular Weight; Nanoparticles; Plasmids; Polyethylene Glycols; Receptors, Cell Surface; Serum; Solubility; Transfection | 2010 |
Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.
Topics: Cations; Cell Line, Tumor; Chitosan; Cholesterol; Drug Delivery Systems; Flow Cytometry; Fluoresceins; Folic Acid; Humans; Hydrogen-Ion Concentration; Kinetics; Liposomes; Magnetic Resonance Spectroscopy; Micelles; Microscopy, Fluorescence; Neoplasms; Particle Size; Permeability; Polyethylene Glycols; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Time Factors | 2010 |
Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells.
Topics: Aminolevulinic Acid; Caco-2 Cells; Carrier Proteins; Cell Line, Tumor; Chitosan; Colorectal Neoplasms; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Nanoparticles; Protoporphyrins; Receptors, Cell Surface | 2010 |
Layer by layer chitosan/alginate coatings on poly(lactide-co-glycolide) nanoparticles for antifouling protection and Folic acid binding to achieve selective cell targeting.
Topics: Alginates; Biocompatible Materials; Chitosan; Drug Delivery Systems; Folic Acid; Glucuronic Acid; Hep G2 Cells; Hexuronic Acids; Humans; Nanoparticles; Polyglactin 910; Serum Albumin, Bovine; Vitamin B Complex | 2010 |
Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chitosan; Drug Carriers; Drug Delivery Systems; Folic Acid; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Nanoparticles; NIH 3T3 Cells; Paclitaxel; Particle Size; Stearic Acids; Surface Properties | 2011 |
Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
Topics: Antibiotics, Antineoplastic; Antioxidants; Biocompatible Materials; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Resistance, Multiple; Folic Acid; Humans; Materials Testing; Micelles; Molecular Structure; Nanoparticles; Pyrrolidines; Thiocarbamates | 2010 |
Folate mediated in vitro targeting of depolymerised trimethylated chitosan having arginine functionality.
Topics: Arginine; Carrier Proteins; Cell Survival; Chitosan; Deoxyribonuclease I; DNA; Drug Carriers; Folate Receptors, GPI-Anchored; Folic Acid; Hemolysis; Humans; KB Cells; Nanoparticles; Polyethylene Glycols; Receptors, Cell Surface; Transfection | 2010 |
Paclitaxel-loaded, folic-acid-targeted and TAT-peptide-conjugated polymeric liposomes: in vitro and in vivo evaluation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Chitosan; Drug Carriers; Drug Compounding; Female; Folate Receptors, GPI-Anchored; Folic Acid; Gene Products, tat; Humans; KB Cells; Liposomes; Mice; Mice, SCID; Microscopy, Electron, Transmission; Paclitaxel; Solubility; Surface Properties; Xenograft Model Antitumor Assays | 2010 |
Folate-targeted drug-delivery systems prepared by nano-comminution.
Topics: Chitosan; Cross-Linking Reagents; Drug Delivery Systems; Drug Stability; Excipients; Folic Acid; Hydrophobic and Hydrophilic Interactions; Nanoparticles; Naproxen; Paclitaxel; Particle Size; Polyphosphates | 2011 |
Ionically crosslinked Ad/chitosan nanocomplexes processed by electrospinning for targeted cancer gene therapy.
Topics: Adenoviridae; Animals; Chitosan; Folic Acid; Gene Transfer Techniques; Genetic Therapy; Humans; Mice; Microscopy, Electron, Transmission; Neoplasms; Polyethylene Glycols | 2010 |
Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
Topics: Animals; Cell Line, Tumor; Chitosan; Contrast Media; Dextrans; Drug Carriers; Folic Acid; Humans; Hydrophobic and Hydrophilic Interactions; Light; Macrophages; Magnetic Resonance Imaging; Magnetics; Magnetite Nanoparticles; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Mononuclear Phagocyte System; Nanotechnology; Neoplasms; Particle Size; Scattering, Radiation; Spectroscopy, Fourier Transform Infrared; Surface Properties; Technology, Pharmaceutical; X-Ray Diffraction | 2011 |
Folate-decorated succinylchitosan nanoparticles conjugated with doxorubicin for targeted drug delivery.
Topics: Animals; Cell Cycle; Cell Death; Cell Survival; Chitosan; Doxorubicin; Drug Delivery Systems; Flow Cytometry; Folic Acid; HeLa Cells; Humans; Hydrogen-Ion Concentration; Indoles; Intracellular Space; Light; Mice; Nanoparticles; NIH 3T3 Cells; Particle Size; Scattering, Radiation; Staining and Labeling; Surface Properties | 2011 |
Alginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasms.
Topics: Alginates; Animals; Biocompatible Materials; Cell Line, Tumor; Chitosan; Colorectal Neoplasms; Drug Carriers; Fluoresceins; Folic Acid; Glucuronic Acid; Hexuronic Acids; Humans; Intestinal Neoplasms; Materials Testing; Mice; Mice, Inbred C57BL; Models, Molecular; Nanoparticles; Photochemistry | 2011 |
Hydrodynamic delivery of chitosan-folate-DNA nanoparticles in rats with adjuvant-induced arthritis.
Topics: Analysis of Variance; Animals; Arthritis, Experimental; beta-Galactosidase; Chitosan; Dinoprostone; Disease Models, Animal; DNA; Drug Delivery Systems; Female; Folic Acid; Freund's Adjuvant; Histocytochemistry; Humans; Injections, Intravenous; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Muscle, Skeletal; Nanoconjugates; Nanoparticles; Rats; Rats, Inbred Lew; Tarsus, Animal; Tissue Distribution | 2011 |
Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells.
Topics: Chitosan; Folic Acid; HT29 Cells; Humans; Nanoparticles | 2011 |
Preparation and characterization of self-assembled nanoparticles based on folic acid modified carboxymethyl chitosan.
Topics: Antineoplastic Agents; Biocompatible Materials; Chitosan; Doxorubicin; Drug Delivery Systems; Folic Acid; Microscopy, Electron, Transmission; Molecular Structure; Nanoparticles | 2011 |
A new family of folate-decorated and carbon nanotube-mediated drug delivery system: synthesis and drug delivery response.
Topics: Chitosan; Doxorubicin; Drug Carriers; Drug Compounding; Folic Acid; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Nanotubes, Carbon; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2011 |
Tumor targeted adenovirus nanocomplex ionically crosslinked by chitosan.
Topics: Adenoviridae; Chitosan; Folic Acid; Genetic Therapy; Humans; Nanostructures; Neoplasms; Polyethylene Glycols; Transduction, Genetic | 2010 |
Targeting tumor cells through chitosan-folate modified microcapsules loaded with camptothecin.
Topics: Adsorption; Animals; Antineoplastic Agents; Camptothecin; Capsules; Cell Proliferation; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Folic Acid; HeLa Cells; Humans; Mice; Molecular Structure; NIH 3T3 Cells; Structure-Activity Relationship; Surface Properties; Tumor Cells, Cultured | 2011 |
Receptor-mediated gene delivery by folic acid-modified stearic acid-grafted chitosan micelles.
Topics: Cell Line, Tumor; Cell Survival; Chitosan; Deoxyribonuclease I; Electrophoretic Mobility Shift Assay; Folate Receptors, GPI-Anchored; Folic Acid; Green Fluorescent Proteins; Humans; Lipids; Micelles; Microscopy, Fluorescence; Particle Size; Plasmids; Recombinant Proteins; Static Electricity; Stearic Acids; Transfection | 2011 |
Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Chitosan; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Flow Cytometry; Fluorescence; Folic Acid; Humans; Inhibitory Concentration 50; Micelles; Microscopy, Electron, Scanning; Paclitaxel; Particle Size; Polymers; Verapamil; X-Ray Diffraction | 2011 |
Radiolabeling of folic acid-modified chitosan with (99m)Tc as potential agents for folate-receptor-mediated targeting.
Topics: Animals; Chitosan; Chromatography, High Pressure Liquid; Folic Acid; Folic Acid Transporters; Mice; Mice, Nude; Organotechnetium Compounds; Radiometry; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Tissue Distribution | 2011 |
[Pharmacokinetics, tissue distribution and magnetic resonance's response characterstics of folic acid-O-carboxymethyl chitosan ultrasmall superparamagnetic iron oxide nanoparticles in mice and rats].
Topics: Animals; Area Under Curve; Chitosan; Contrast Media; Dose-Response Relationship, Drug; Drug Carriers; Ferric Compounds; Folic Acid; Injections, Intravenous; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Mice; Nanoparticles; Particle Size; Phagocytosis; Random Allocation; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2011 |
Process optimization for the preparation of oligomycin-loaded folate-conjugated chitosan nanoparticles as a tumor-targeted drug delivery system using a two-level factorial design method.
Topics: Analysis of Variance; Antineoplastic Agents; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Folic Acid; Freeze Drying; Nanomedicine; Nanoparticles; Oligomycins; Particle Size; Spectroscopy, Fourier Transform Infrared | 2011 |
Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan-folic acid micelles.
Topics: Absorbable Implants; Breast Neoplasms; Cell Membrane; Cell Nucleus; Chitosan; Drug Carriers; Female; Folic Acid; Humans; Micelles; Microscopy, Fluorescence; Paclitaxel; Rhodamines; Solubility; Tumor Cells, Cultured | 2012 |
Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Compounding; Drug Delivery Systems; Female; Folic Acid; HeLa Cells; Humans; Lactic Acid; Lipids; Mice; Mice, SCID; Nanoparticles; Paclitaxel; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Tissue Distribution | 2012 |
Luminescent/magnetic hybrid nanoparticles with folate-conjugated peptide composites for tumor-targeted drug delivery.
Topics: Antineoplastic Agents, Phytogenic; Cadmium Compounds; Camptothecin; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Folic Acid; Humans; Luminescence; Luminescent Agents; Magnetite Nanoparticles; Micelles; Neoplasms; Oligopeptides; Quantum Dots; Tellurium | 2012 |
Synthesis and characterization of folic acid modified water-soluble chitosan derivatives for folate-receptor-mediated targeting.
Topics: Chitosan; Feasibility Studies; Folic Acid; Magnetic Resonance Spectroscopy; Receptors, Cell Surface; Solubility; Spectrophotometry, Ultraviolet | 2012 |
Folate conjugated chitosan grafted thiazole orange derivative with high targeting for early breast cancer cells diagnosis.
Topics: Amines; Animals; Benzothiazoles; Breast Neoplasms; Cattle; Chitosan; Drug Design; Early Detection of Cancer; Fluorescent Dyes; Folate Receptors, GPI-Anchored; Folic Acid; Humans; MCF-7 Cells; Quinolines; Serum Albumin, Bovine; Temperature | 2012 |
In vitro antimicrobial activity of nanoconjugated vancomycin against drug resistant Staphylococcus aureus.
Topics: Adsorption; Anti-Bacterial Agents; Chitosan; Diethylamines; Drug Resistance, Bacterial; Folic Acid; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Nanoparticles; Potassium; Sodium-Potassium-Exchanging ATPase; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Vancomycin | 2012 |
Tissue distribution and pharmacokinetics evaluation of DOMC-FA micelles for intravenous delivery of PTX.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Calorimetry, Differential Scanning; Chitosan; Deoxycholic Acid; Drug Carriers; Folic Acid; Injections, Intravenous; Mice; Mice, Inbred Strains; Micelles; Microscopy, Electron, Transmission; Organ Specificity; Paclitaxel; Particle Size; Rabbits; Solubility; Surface Properties; Tissue Distribution | 2013 |
Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies.
Topics: Cell Line, Tumor; Chitosan; Folic Acid; Gene Silencing; HeLa Cells; Humans; Molecular Weight; Nanocapsules; Neoplasms, Experimental; RNA, Small Interfering; Transfection | 2012 |
In vitro evaluation on novel modified chitosan for targeted antitumor drug delivery.
Topics: Antineoplastic Agents; Breast Neoplasms; Chitosan; Drug Carriers; Female; Folic Acid; Humans; MCF-7 Cells; Micelles; Paclitaxel; Polymers | 2013 |
Cancer cell targeting and imaging with biopolymer-based nanodevices.
Topics: Animals; Chitosan; Contrast Media; Drug Stability; Drug Storage; Female; Flow Cytometry; Folate Receptors, GPI-Anchored; Folic Acid; Gadolinium; HeLa Cells; Humans; Magnetic Resonance Imaging; Mice; Mice, Nude; Microscopy, Confocal; Nanoparticles; Particle Size; Polyglutamic Acid; Time Factors; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2013 |
pH-responsive mechanism of a deoxycholic acid and folate comodified chitosan micelle under cancerous environment.
Topics: Capsules; Cell Proliferation; Cell Survival; Chitosan; Delayed-Action Preparations; Deoxycholic Acid; Doxorubicin; Drug Carriers; Epithelial Cells; Folic Acid; Folic Acid Transporters; HeLa Cells; Humans; Hydrogen-Ion Concentration; Micelles | 2013 |
Iron nanoparticles from animal blood for cellular imaging and targeted delivery for cancer treatment.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Folic Acid; Goats; Humans; Iron; Magnetic Resonance Imaging; Metal Nanoparticles; Mice; Microscopy, Phase-Contrast; NIH 3T3 Cells; Particle Size; Spectroscopy, Fourier Transform Infrared | 2013 |
Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Mice; Mice, Nude; Micelles; Neoplasms; Rats | 2013 |
Biocompatible magnetic and molecular dual-targeting polyelectrolyte hybrid hollow microspheres for controlled drug release.
Topics: Antineoplastic Agents; Biocompatible Materials; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Folic Acid; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Magnetite Nanoparticles; Materials Testing; Microspheres; Polyethylene Glycols; Polystyrenes | 2013 |
Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy.
Topics: Adaptive Immunity; Adenoviridae; Animals; Chitosan; Folic Acid; Genetic Therapy; Male; Mice; Mice, Nude; Neoplasms; Oncolytic Virotherapy; Oncolytic Viruses; Polyethylene Glycols | 2013 |
Folic acid conjugated glycol chitosan micelles for targeted delivery of doxorubicin: preparation and preliminary evaluation in vitro.
Topics: Antibiotics, Antineoplastic; Cell Survival; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; HeLa Cells; Humans; Micelles; Neoplasms | 2013 |
Antioxidative effect of folate-modified chitosan nanoparticles.
Topics: Animals; Antioxidants; Chitosan; DNA Fragmentation; Folic Acid; Glutathione; Glutathione Transferase; Male; Mice; Nanoparticles; Nicotine; Organ Specificity; Oxidoreductases | 2011 |
Biocompatibility of folate-modified chitosan nanoparticles.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; Chitosan; Ethylamines; Folic Acid; HeLa Cells; Humans; Male; Materials Testing; Mice; Microbial Sensitivity Tests; Nanoparticles; Staphylococcus aureus; Vancomycin | 2012 |
Therapeutic efficiency of folated poly(ethylene glycol)-chitosan-graft-polyethylenimine-Pdcd4 complexes in H-ras12V mice with liver cancer.
Topics: Animals; Apoptosis Regulatory Proteins; Chitosan; DNA; Drug Carriers; Folic Acid; Genes, ras; Hep G2 Cells; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Transgenic; Nanoparticles; Polyethylene Glycols; Polyethyleneimine; Random Allocation; RNA-Binding Proteins; Transfection; Xenograft Model Antitumor Assays | 2013 |
Preparation and characterization of folate-chitosan-gemcitabine core-shell nanoparticles for potential tumor-targeted drug delivery.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Deoxycytidine; Diffusion; Folic Acid; Gemcitabine; Humans; Materials Testing; Nanocapsules; Pancreatic Neoplasms; Porosity; Treatment Outcome | 2013 |
Biocompatible multi-walled carbon nanotube-chitosan-folic acid nanoparticle hybrids as GFP gene delivery materials.
Topics: Biocompatible Materials; Cell Survival; Chitosan; Folic Acid; Gene Transfer Techniques; Green Fluorescent Proteins; HeLa Cells; Humans; MCF-7 Cells; Microscopy, Fluorescence; Nanoparticles; Nanotubes, Carbon; Spectroscopy, Fourier Transform Infrared; Static Electricity; Transfection | 2013 |
Photodynamic detection of oral cancers with high-performance chitosan-based nanoparticles.
Topics: Animals; Cell Line, Tumor; Chitosan; Female; Fluoresceins; Fluorescent Dyes; Folic Acid; Folic Acid Transporters; Humans; Hydrogen-Ion Concentration; Lysosomes; Mice; Mice, Inbred ICR; Mice, SCID; Mouth Neoplasms; Nanoparticles; Neoplasm Transplantation; Optical Imaging; Particle Size; Protoporphyrins; Succinic Anhydrides | 2013 |
A novel drug "copper acetylacetonate" loaded in folic acid-tagged chitosan nanoparticle for efficient cancer cell targeting.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Chitosan; Folic Acid; Glutathione; HEK293 Cells; HeLa Cells; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Hydroxybutyrates; MCF-7 Cells; Membrane Potential, Mitochondrial; Mice; Nanoparticles; NIH 3T3 Cells; Pentanones; Reactive Oxygen Species; Solubility | 2014 |
A pH-sensitive gene delivery system based on folic acid-PEG-chitosan - PAMAM-plasmid DNA complexes for cancer cell targeting.
Topics: Animals; Cell Line, Tumor; Chitosan; Dendrimers; DNA; Female; Folic Acid; Gene Transfer Techniques; Hep G2 Cells; Humans; Mice; Mice, Nude; Plasmids; Polyethylene Glycols | 2013 |
Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Topics: Animals; Carbocyanines; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Female; Fluorescent Dyes; Folic Acid; Gene Knockdown Techniques; Genetic Therapy; Hemolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Nude; Nanoparticles; Ovarian Neoplasms; Polyethylene Glycols; RNA, Small Interfering | 2014 |
Effects of poly(ethylene glycol) grafting density on the tumor targeting efficacy of nanoparticles with ligand modification.
Topics: Animals; Animals, Outbred Strains; Antineoplastic Agents, Phytogenic; Biological Transport; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Compounding; Drug Delivery Systems; Folic Acid; Humans; Ligands; Linoleic Acid; Liver; Liver Neoplasms, Experimental; Malates; Male; Mice; Nanoparticles; Paclitaxel; Particle Size; Polyethylene Glycols; Polymers; Random Allocation; Surface Properties; Tissue Distribution | 2015 |
Folic acid-chitosan conjugated nanoparticles for improving tumor-targeted drug delivery.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Delivery Systems; Folic Acid; Folic Acid Transporters; Humans; Nanoparticles; Neoplasm Proteins; Neoplasms; Phagocytosis | 2013 |
Water soluble folate-chitosan nanogels crosslinked by genipin.
Topics: Chitosan; Drug Carriers; Folic Acid; Hydrogen-Ion Concentration; Iridoids; Nanostructures; Solubility; Water | 2014 |
Folic acid-conjugated, SERS-labeled silver nanotriangles for multimodal detection and targeted photothermal treatment on human ovarian cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Drug Delivery Systems; Female; Folic Acid; Hot Temperature; Humans; Lasers; Metal Nanoparticles; Multimodal Imaging; Ovarian Neoplasms; Silver; Spectrum Analysis, Raman; Surface Plasmon Resonance | 2014 |
Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Cell Survival; Chitosan; Deoxycholic Acid; Diffusion; Doxorubicin; Folic Acid; HeLa Cells; Humans; Materials Testing; Mice; Nanocapsules; Particle Size; Polyethylene Glycols | 2014 |
Tumor-specific localization of self-assembled nanoparticle PET/MR modalities.
Topics: Animals; Carcinoma, Hepatocellular; Cell Proliferation; Chitosan; Contrast Media; Flow Cytometry; Folate Receptors, GPI-Anchored; Folic Acid; Liver Neoplasms; Magnetic Resonance Imaging; Male; Nanoparticles; Polyglutamic Acid; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 2014 |
Folate-polyethylene glycol conjugated carboxymethyl chitosan for tumor-targeted delivery of 5-fluorouracil.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Fluorouracil; Folic Acid; HeLa Cells; Hep G2 Cells; Humans; Polyethylene Glycols | 2014 |
Preparation, in vitro and in vivo evaluation of bexarotene nanocrystals with surface modification by folate-chitosan conjugates.
Topics: Animals; Anticarcinogenic Agents; Area Under Curve; Bexarotene; Biological Availability; Chemistry, Pharmaceutical; Chitosan; Folic Acid; Male; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley; Surface Properties; Suspensions; Tetrahydronaphthalenes | 2016 |
Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes.
Topics: Adsorption; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Deoxyribonuclease I; Drug Delivery Systems; Endocytosis; Female; Folic Acid; Gene Transfer Techniques; Humans; Inhibitor of Apoptosis Proteins; Linoleic Acid; Malates; Mice; Nanoparticles; Paclitaxel; Particle Size; Polymers; Repressor Proteins; RNA, Messenger; Serum Albumin, Bovine; Static Electricity; Surface-Active Agents; Survivin | 2014 |
Folate-targeted liposome encapsulating chitosan/oligonucleotide polyplexes for tumor targeting.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Colloids; Drug Compounding; Drug Delivery Systems; Folic Acid; Liposomes; Melanoma, Experimental; Mice; Oligonucleotides; Particle Size | 2014 |
Facile synthesis of multilayered polysaccharidic vesicles.
Topics: Amylases; Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Drug Carriers; Female; Folic Acid; Folic Acid Transporters; Humans; Hyaluronic Acid; Mice, Nude; Neoplasms; Peptides; Polyethylene Glycols; Polylysine; Serum Albumin, Bovine; Starch | 2014 |
Endosomal pH responsive polymers for efficient cancer targeted gene therapy.
Topics: Animals; Biological Transport; Cell Survival; Chitosan; CHO Cells; Cricetulus; Drug Compounding; Endosomes; Fluorescent Dyes; Folate Receptors, GPI-Anchored; Folic Acid; Gene Transfer Techniques; HeLa Cells; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Imidazoles; Liposomes; Microscopy, Fluorescence; Plasmids; Schiff Bases | 2014 |
Folate-targeted multifunctional amino acid-chitosan nanoparticles for improved cancer therapy.
Topics: Amino Acids; Antineoplastic Agents; Chitosan; Coculture Techniques; Drug Carriers; Drug Delivery Systems; Folic Acid; HeLa Cells; Humans; Nanoparticles; Neoplasms | 2015 |
In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Female; Folic Acid; Humans; Mice; Micelles; Paclitaxel; Polyethylene Glycols | 2016 |
Microencapsulation of coupled folate and chitosan nanoparticles for targeted delivery of combination drugs to colon.
Topics: Capsules; Chitosan; Colon; Colonic Neoplasms; Drug Carriers; Folic Acid; Humans; Nanoparticles; Polymethacrylic Acids | 2015 |
Self-organized nanoparticles based on chitosan-folic acid and dextran succinate-doxorubicin conjugates for drug targeting.
Topics: Animals; Antibiotics, Antineoplastic; Chitosan; Dextrans; Doxorubicin; Drug Carriers; Female; Folic Acid; Folic Acid Transporters; Humans; KB Cells; Mice, Nude; Nanoparticles; Particle Size; Xenograft Model Antitumor Assays | 2014 |
Synthesis of Tat tagged and folate modified N-succinyl-chitosan self-assembly nanoparticles as a novel gene vector.
Topics: Cations; Chitosan; DNA; Folic Acid; Gene Transfer Techniques; Green Fluorescent Proteins; Humans; Nanoparticles; Spectroscopy, Fourier Transform Infrared; tat Gene Products, Human Immunodeficiency Virus | 2015 |
Synthesis of size-tunable chitosan encapsulated gold-silver nanoflowers and their application in SERS imaging of living cells.
Topics: Benzoxazines; Chitosan; Folic Acid; Gold; HeLa Cells; Humans; Microscopy, Electron, Transmission; Nanostructures; Silver; Spectrum Analysis, Raman | 2015 |
Inorganic nanovehicle for potential targeted drug delivery to tumor cells, tumor optical imaging.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Ferrosoferric Oxide; Fluorouracil; Folic Acid; HEK293 Cells; HeLa Cells; Humans; Magnetite Nanoparticles; Microscopy, Confocal; Nanostructures; Rhodamines; Zirconium | 2015 |
High molecular weight chitosan derivative polymeric micelles encapsulating superparamagnetic iron oxide for tumor-targeted magnetic resonance imaging.
Topics: Animals; Chitosan; Contrast Media; Folic Acid; HeLa Cells; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Micelles; Neoplasms | 2015 |
Ligand-functionalized degradable polyplexes formed by cationic poly(aspartic acid)-grafted chitosan-cyclodextrin conjugates.
Topics: Cations; Chitosan; Cyclodextrins; DNA; Drug Implants; Folate Receptors, GPI-Anchored; Folic Acid; HeLa Cells; Humans; Nanocapsules; Nanoconjugates; Particle Size; Peptides; Transfection | 2015 |
siRNA Inhibition of Endocytic Pathways to Characterize the Cellular Uptake Mechanisms of Folate-Functionalized Glycol Chitosan Nanogels.
Topics: Blotting, Western; Chitosan; Electrophoresis, Polyacrylamide Gel; Endocytosis; Flow Cytometry; Folic Acid; HeLa Cells; Humans; Nanogels; Polyethylene Glycols; Polyethyleneimine; RNA, Small Interfering | 2015 |
A novel micelle-forming material used for preparing a theranostic vehicle exhibiting enhanced in vivo therapeutic efficacy.
Topics: Animals; Antineoplastic Agents; Camptothecin; Carbocyanines; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Drug Carriers; Female; Ferric Compounds; Fluorescence; Fluorescent Dyes; Folic Acid; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Magnetic Fields; Magnets; Mice, Nude; Micelles; Nanoparticles; Sonication | 2015 |
Anti-tumor immune response of folate-conjugated chitosan nanoparticles containing the IP-10 gene in mice with hepatocellular carcinoma.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chemokine CXCL10; Chitosan; Cricetinae; DNA; Female; Folic Acid; Immunotherapy; Interferon gamma Receptor; Liver Neoplasms; Mice; Mice, Inbred BALB C; Nanocapsules; Particle Size; Receptors, Interferon; Transfection; Treatment Outcome | 2014 |
Development of (153) Sm-folate-polyethyleneimine-conjugated chitosan nanoparticles for targeted therapy.
Topics: Animals; Breast Neoplasms; Cell Survival; Chitosan; Drug Carriers; Female; Folic Acid; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanoparticles; Organometallic Compounds; Organophosphorus Compounds; Polyethyleneimine; Radiopharmaceuticals; Samarium; Spectroscopy, Fourier Transform Infrared; Tissue Distribution | 2015 |
Folate-conjugated chitosan-poly(ethylenimine) copolymer as an efficient and safe vector for gene delivery in cancer cells.
Topics: Animals; Aziridines; Cell Line, Tumor; Chitosan; Folate Receptors, GPI-Anchored; Folic Acid; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Melanoma, Experimental; Mice; Neoplasms; Polymers; Transfection | 2015 |
A novel preparation method of paclitaxcel-loaded folate-modified chitosan microparticles and in vitro evaluation.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Cell Line; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Fibroblasts; Folic Acid; Humans; Liver Neoplasms; Mice; Nanoparticles; Paclitaxel | 2016 |
Oligoethylenimine-grafted chitosan as enhanced T1 contrast agent for in vivo targeted tumor MRI.
Topics: Animals; Aziridines; Cell Line, Tumor; Chitosan; Contrast Media; Folate Receptors, GPI-Anchored; Folic Acid; Gadolinium DTPA; Image Enhancement; Magnetic Resonance Imaging; Mice; Mice, Nude; Molecular Probe Techniques; Neoplasms, Experimental; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Chitosan; Doxorubicin; Drug Compounding; Drug Design; Drug Liberation; Folic Acid; Folic Acid Transporters; Humans; Hydrogen-Ion Concentration; Hyperthermia, Induced; Magnetic Phenomena; Magnetite Nanoparticles; MCF-7 Cells; Mice; Neoplasms; NIH 3T3 Cells; Theranostic Nanomedicine | 2016 |
A magnetic vehicle realized tumor cell-targeted radiotherapy using low-dose radiation.
Topics: Animals; Chitosan; Chlorophyllides; Drug Delivery Systems; Female; Ferric Compounds; Folic Acid; HeLa Cells; Humans; Magnets; Mice, Nude; Micelles; Neoplasms; Porphyrins; Radiation-Sensitizing Agents | 2016 |
Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery.
Topics: Cell Line; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Folic Acid; HeLa Cells; Humans; Methotrexate; Nanoparticles; Particle Size | 2017 |
Folate-modified Chitosan Nanoparticles Containing the IP-10 Gene Enhance Melanoma-specific Cytotoxic CD8(+)CD28(+) T Lymphocyte Responses.
Topics: Adoptive Transfer; Animals; CD28 Antigens; CD8-Positive T-Lymphocytes; Chemokine CXCL10; Chitosan; Cytotoxicity, Immunologic; Disease Models, Animal; Drug Carriers; Folic Acid; Melanoma; Mice; Nanoparticles; Survival Analysis; Treatment Outcome | 2016 |
Folate-Modified Chitosan Nanoparticles Coated Interferon-Inducible Protein-10 Gene Enhance Cytotoxic T Lymphocytes' Responses to Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Chemokine CXCL10; Chitosan; Coated Materials, Biocompatible; Folate Receptors, GPI-Anchored; Folic Acid; Immunotherapy, Adoptive; Mice; Mice, Inbred BALB C; Mice, Nude; Nanocapsules; Survival Rate; T-Lymphocytes, Cytotoxic; Treatment Outcome | 2016 |
Preparation, characterization and biodistribution in quails of
Topics: Animals; Chitosan; Chromatography, Gel; Female; Folic Acid; Hydrogen-Ion Concentration; Male; Molecular Weight; Nanostructures; Particle Size; Proton Magnetic Resonance Spectroscopy; Quail; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Surface Properties; Technetium; Time Factors; Tin; Tissue Distribution; X-Ray Diffraction | 2016 |
Folate-Chitosan Nanoparticles Loaded with Ursolic Acid Confer Anti-Breast Cancer Activities in vitro and in vivo.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Cell Survival; Chitosan; Female; Folic Acid; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Mice; Mitochondria; Nanoparticles; Triterpenes; Ursolic Acid; Xenograft Model Antitumor Assays | 2016 |
Paclitaxel loaded magnetic nanocomposites with folate modified chitosan/carboxymethyl surface; a vehicle for imaging and targeted drug delivery.
Topics: Antineoplastic Agents, Phytogenic; Cell Survival; Chitosan; Drug Delivery Systems; Drug Liberation; Erythrocytes; Ferric Compounds; Folic Acid; Hemolysis; Humans; Magnetic Phenomena; MCF-7 Cells; Nanocomposites; Neoplasms; Nickel; Paclitaxel; Serum Albumin, Bovine | 2016 |
Magnetic core-shell hybrid nanoparticles for receptor targeted anti-cancer therapy and magnetic resonance imaging.
Topics: Antineoplastic Agents; Carbodiimides; Cell Line, Tumor; Chitosan; Contrast Media; Cross-Linking Reagents; Docetaxel; Drug Compounding; Drug Liberation; Epithelial Cells; Ferric Compounds; Folate Receptor 1; Folic Acid; Gene Expression; Humans; Hydrogen-Ion Concentration; Kinetics; Lactic Acid; Magnetic Resonance Imaging; Magnetite Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Taxoids | 2017 |
Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Doxorubicin; Drug Delivery Systems; Drug Liberation; Endocytosis; Female; Folic Acid; Humans; Immunity, Cellular; Immunity, Humoral; Interleukin-2; Mice; Nanoparticles | 2017 |
Nanogold-Gallate Chitosan-Targeted Pulmonary Delivery for Treatment of Lung Cancer.
Topics: Antineoplastic Agents; Biocompatible Materials; Chitosan; Cisplatin; Drug Delivery Systems; Excipients; Folic Acid; Gallic Acid; Gold; Humans; Lung Neoplasms; Metal Nanoparticles | 2017 |
Fabrication of functional hollow microspheres constructed from MOF shells: Promising drug delivery systems with high loading capacity and targeted transport.
Topics: Biological Transport; Cell Line, Tumor; Cell Survival; Chitosan; Drug Delivery Systems; Drug Liberation; Fluoresceins; Fluorouracil; Folic Acid; Humans; Metal-Organic Frameworks; Microspheres; Nanoparticles; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2016 |
Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics.
Topics: A549 Cells; Animals; Biological Transport; Chitosan; Delayed-Action Preparations; Deoxycytidine; Drug Carriers; Drug Liberation; Folic Acid; Gemcitabine; Humans; Lung Neoplasms; Mice; Nanoparticles; Particle Size; Polyethylene Glycols; Tissue Distribution | 2017 |
Novel amphiphilic folic acid-cholesterol-chitosan micelles for paclitaxel delivery.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Chitosan; Cholesterol; Drug Liberation; Folic Acid; Humans; Hydrogen-Ion Concentration; Micelles; Paclitaxel; Particle Size; Proton Magnetic Resonance Spectroscopy | 2017 |
Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Chitosan; Delayed-Action Preparations; Diffusion; Female; Folate Receptors, GPI-Anchored; Folic Acid; Hydrogen-Ion Concentration; Injections, Intravenous; Mice; Molecular Targeted Therapy; Nanocapsules; Nanoconjugates; Neoplasms, Experimental; Paclitaxel; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2017 |
Core-shell drug carrier from folate conjugated chitosan obtained from prawn shell for targeted doxorubicin delivery.
Topics: Animal Shells; Animals; Cell Separation; Chitosan; Doxorubicin; Drug Carriers; Ferric Compounds; Flow Cytometry; Folic Acid; Hydrogen-Ion Concentration; Magnetics; Metal Nanoparticles; Microscopy, Electron, Scanning; Penaeidae; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Static Electricity; Temperature | 2017 |
Fabrication and study of curcumin loaded nanoparticles based on folate-chitosan for breast cancer therapy application.
Topics: Breast Neoplasms; Chitosan; Curcumin; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Hydrogen-Ion Concentration; Nanoparticles; Particle Size | 2017 |
Folic acid functionalized reduction-responsive magnetic chitosan nanocapsules for targeted delivery and triggered release of drugs.
Topics: Chitosan; Coumarins; Drug Delivery Systems; Drug Liberation; Folic Acid; HeLa Cells; Humans; Magnetics; Nanocapsules; Thiazoles | 2017 |
Tat-Tagged and Folate-Modified N-Succinyl-chitosan (Tat-Suc-FA) Self-assembly Nanoparticle for Therapeutic Delivery OGX-011 to A549 Cells.
Topics: A549 Cells; Chitosan; Drug Carriers; Folic Acid; Humans; Nanoparticles; Thionucleotides | 2017 |
Chitosan-folate decorated carbon nanotubes for site specific lung cancer delivery.
Topics: Chitosan; Folic Acid; Humans; Lung; Lung Neoplasms; Nanotubes, Carbon | 2017 |
Synthesis of folate‑chitosan nanoparticles loaded with ligustrazine to target folate receptor positive cancer cells.
Topics: A549 Cells; Chitosan; Drug Liberation; Endocytosis; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Nanoparticles; Neoplasms; Proton Magnetic Resonance Spectroscopy; Pyrazines; Spectrophotometry, Infrared; Time Factors | 2017 |
Folate and Heptamethine Cyanine Modified Chitosan-Based Nanotheranostics for Tumor Targeted Near-Infrared Fluorescence Imaging and Photodynamic Therapy.
Topics: Carbocyanines; Chitosan; Drug Delivery Systems; Fluorescence; Folic Acid; HeLa Cells; Hep G2 Cells; Humans; Infrared Rays; Nanoparticles; Neoplasms; Photochemotherapy; Theranostic Nanomedicine | 2017 |
Mouse IP-10 Gene Delivered by Folate-modified Chitosan Nanoparticles and Dendritic/tumor Cells Fusion Vaccine Effectively Inhibit the Growth of Hepatocellular Carcinoma in Mice.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Chemokine CXCL10; Chitosan; Dendritic Cells; Disease Models, Animal; Drug Carriers; Folic Acid; Heterografts; Mice; Mice, Inbred C57BL; Nanoparticles; Treatment Outcome; Vaccines, DNA | 2017 |
A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Movement; Chitosan; Drug Delivery Systems; Folic Acid; HeLa Cells; Hep G2 Cells; Humans; Hyaluronan Receptors; Hydrogen-Ion Concentration; Matrix Metalloproteinase 9; Mice; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Poly (ADP-Ribose) Polymerase-1; Proto-Oncogene Proteins c-bcl-2; PTEN Phosphohydrolase; Signal Transduction; Triterpenes; Tumor Suppressor Protein p53; Ursolic Acid | 2017 |
tRNA conjugation with folic acid-chitosan conjugates.
Topics: Chitosan; Folic Acid; Nanoparticles; RNA, Transfer; Thermodynamics | 2017 |
DNA binding to folic acid-chitosan nanoconjugates.
Topics: Animals; Cattle; Chitosan; DNA; Folic Acid; Kinetics; Nanoconjugates; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Thermodynamics | 2018 |
Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
Topics: Animals; Cell Line; Cell Line, Tumor; Cell Survival; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Fluorouracil; Folic Acid; Humans; MCF-7 Cells; Mice; Nanoparticles; Particle Size; Polyethylene Glycols; Polymers; RAW 264.7 Cells | 2018 |
Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.
Topics: Alginates; Animals; Biocompatible Materials; Catechols; Cell Line; Chitosan; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Drug Delivery Systems; Epithelial Cells; Folic Acid; Glucuronic Acid; Heme Oxygenase-1; Hexuronic Acids; Hydrogels; Interleukin-1beta; Interleukin-6; Intestinal Mucosa; Macrophages; Membrane Proteins; Mice; Nanoparticles; NF-E2-Related Factor 2; Nitric Oxide Synthase Type II; Polyethylene Glycols; RNA, Messenger; Tumor Necrosis Factor-alpha; Wound Healing | 2018 |
Natural and synthetic polymer for graphene oxide mediated anticancer drug delivery-A comparative study.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Drug Carriers; Drug Delivery Systems; Folic Acid; Graphite; Humans; Microscopy, Atomic Force; Oxides; Polymers; Povidone; Spectroscopy, Fourier Transform Infrared | 2018 |
Synthesis and characterization of cystamine conjugated chitosan-SS-mPEG based 5-Fluorouracil loaded polymeric nanoparticles for redox responsive drug release.
Topics: Biological Transport; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Cystamine; Drug Delivery Systems; Drug Liberation; Fluorouracil; Folic Acid; Humans; MCF-7 Cells; Nanoparticles; Oxidation-Reduction; Particle Size; Polyethylene Glycols; Surface Properties | 2018 |
The effects of ligand valency and density on the targeting ability of multivalent nanoparticles based on negatively charged chitosan nanoparticles.
Topics: Animals; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Drug Delivery Systems; Endocytosis; Female; Folic Acid; Hep G2 Cells; Humans; Ligands; Metabolic Clearance Rate; Nanoparticles; Rats, Sprague-Dawley; Vitamin B Complex | 2018 |
Natural material-decorated mesoporous silica nanoparticle container for multifunctional membrane-controlled targeted drug delivery.
Topics: Biocompatible Materials; Cell Death; Chitosan; Drug Delivery Systems; Drug Liberation; Endocytosis; Folic Acid; Hep G2 Cells; Humans; Membranes, Artificial; Nanoparticles; Particle Size; Porosity; Silicon Dioxide; Spectroscopy, Fourier Transform Infrared; Static Electricity; Temperature | 2017 |
pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Nucleus; Chitosan; Doxorubicin; Drug Carriers; Drug Resistance, Neoplasm; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Hydrogen-Ion Concentration; Nanoparticles; Selenium | 2018 |
New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
Topics: Administration, Inhalation; Albumins; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Drug Compounding; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Lipids; Lung; Lung Neoplasms; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Polyethylene Glycols; Surface Properties; Tissue Distribution; Xenograft Model Antitumor Assays | 2018 |
Positively charged gold nanoparticles capped with folate quaternary chitosan: Synthesis, cytotoxicity, and uptake by cancer cells.
Topics: Caco-2 Cells; Chitosan; Endocytosis; Folic Acid; Gold; Green Chemistry Technology; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Metal Nanoparticles; Quaternary Ammonium Compounds; Static Electricity | 2018 |
Development of novel biofunctionalized chitosan decorated nanocochleates as a cancer targeted drug delivery platform.
Topics: Animals; Chelating Agents; Chitosan; Dimyristoylphosphatidylcholine; Doxorubicin; Drug Carriers; Drug Liberation; Female; Folic Acid; Humans; MCF-7 Cells; Mice; Nanoparticles; Rats; Rats, Wistar; Tissue Distribution | 2018 |
In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice.
Topics: Alkaline Phosphatase; Animals; Arthritis, Experimental; Biomarkers; Bone Resorption; Cartilage; Cell Survival; Chitosan; Disease Progression; Female; Folic Acid; Gene Transfer Techniques; Inflammation Mediators; Joints; Mice, Inbred DBA; Nanoparticles; Osteocalcin; Peptide Fragments; Polyethylene Glycols; Procollagen; RNA, Small Interfering; Tartrate-Resistant Acid Phosphatase; Treatment Outcome; Tumor Necrosis Factor-alpha; X-Ray Microtomography | 2018 |
Chitosan Stabilized Gold-Folate-Poly(lactide-co-glycolide) Nanoplexes Facilitate Efficient Gene Delivery in Hepatic and Breast Cancer Cells.
Topics: Breast Neoplasms; Chitosan; Female; Folic Acid; Genetic Therapy; Gold; Humans; Lactic Acid; Nanoparticles; Particle Size; Polyglactin 910; Polyglycolic Acid | 2018 |
Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy.
Topics: Animals; Bone Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; Chitosan; Dendrimers; Folic Acid; Gene Silencing; Genetic Therapy; Humans; Male; Matrix Metalloproteinase 2; Membrane Proteins; Mice, Nude; Nanoparticles; Osteosarcoma; Polylysine; RNA-Binding Proteins; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2018 |
Design of functionalized folic acid-chitosan nanoparticles for delivery of tetracycline, doxorubicin, and tamoxifen.
Topics: Chitosan; Doxorubicin; Drug Carriers; Folic Acid; Microscopy, Electron, Transmission; Nanoparticles; Spectroscopy, Fourier Transform Infrared; Tamoxifen; Tetracyclines; Thermodynamics | 2019 |
Synthesis and in vitro study of modified chitosan-polycaprolactam nanocomplex as delivery system.
Topics: Caprolactam; Cell Survival; Chemistry Techniques, Synthetic; Chitosan; Drug Carriers; Drug Liberation; Folic Acid; Humans; MCF-7 Cells; Nanostructures | 2018 |
Preparation and evaluation of a chitosan-coated antioxidant liposome containing vitamin C and folic acid.
Topics: Antioxidants; Ascorbic Acid; Biphenyl Compounds; Chitosan; Drug Liberation; Drug Stability; Folic Acid; Free Radicals; Hydrogen Peroxide; Liposomes; Picrates; Vitamins | 2018 |
Conjugates of TAT and folate with DOX-loaded chitosan micelles offer effective intracellular delivery ability.
Topics: Animals; Arginine; Cell Line, Tumor; Cell-Penetrating Peptides; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Mice; Mice, Nude; Micelles; Polyethylene Glycols; Polymers; Xenograft Model Antitumor Assays | 2019 |
Chitosan-Carboxymethyl-5-Fluorouracil-Folate Conjugate Particles: Microwave Modulated Uptake by Skin and Melanoma Cells.
Topics: Administration, Cutaneous; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Fluorouracil; Folic Acid; Humans; Melanoma; Membrane Microdomains; Microwaves; Nanoparticles; Skin; Skin Absorption; Skin Neoplasms | 2018 |
Folic acid-conjugated chitosan oligosaccharide-magnetic halloysite nanotubes as a delivery system for camptothecin.
Topics: Antineoplastic Agents; Camptothecin; Cell Proliferation; Cell Survival; Chitosan; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Screening Assays, Antitumor; Folic Acid; Humans; Nanotubes; Oligosaccharides; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
Folate-modified carboxymethyl-chitosan/polyethylenimine/bovine serum albumin based complexes for tumor site-specific drug delivery.
Topics: A549 Cells; Animals; Antineoplastic Agents; Cell Survival; Chitosan; Drug Delivery Systems; Drug Liberation; Folic Acid; Humans; Male; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Polyethyleneimine; Serum Albumin, Bovine; TNF-Related Apoptosis-Inducing Ligand; Tumor Burden; Xanthones | 2018 |
Amphiphilic Polymeric Micelles Based on Deoxycholic Acid and Folic Acid Modified Chitosan for the Delivery of Paclitaxel.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Deoxycholic Acid; Drug Carriers; Female; Folic Acid; Humans; Injections, Intravenous; Liver Neoplasms; MCF-7 Cells; Mice; Micelles; Neoplasm Transplantation; Paclitaxel; Particle Size; Xenograft Model Antitumor Assays | 2018 |
Fabrication and characterization of pH-sensitive bio-nanocomposite beads havening folic acid intercalated LDH and chitosan: Drug release and mechanism evaluation.
Topics: Chitosan; Drug Carriers; Drug Liberation; Folic Acid; Hydrogen-Ion Concentration; Hydroxides; Microspheres; Nanocomposites | 2019 |
Research of Gene Delivery Mediated by Ultrasound, Microbubble and Folate-modified Chitosan Nanoparticles.
Topics: Cell Line; Chitosan; Folic Acid; Gene Transfer Techniques; Humans; Microbubbles; Nanoparticles; Plasmids; Ultrasonic Waves | 2018 |
A smart tumor microenvironment responsive nanoplatform based on upconversion nanoparticles for efficient multimodal imaging guided therapy.
Topics: Animals; Biocompatible Materials; Cell Survival; Chitosan; Doxorubicin; Drug Carriers; Female; Folic Acid; HeLa Cells; Hemolysis; Humans; Infrared Rays; Mice; Microscopy, Confocal; Nanoparticles; Neoplasms; Porosity; Silicon Dioxide; Tomography, X-Ray Computed; Tungsten Compounds | 2019 |
Preparation and properties of carbon nanotube (Fe)/hydroxyapatite composite as magnetic targeted drug delivery carrier.
Topics: Antineoplastic Agents; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Durapatite; Folic Acid; Hydrogen-Ion Concentration; Iron; Magnets; Microscopy, Electron, Scanning; Nanotubes, Carbon; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared | 2019 |
Magnetic bio-metal-organic framework nanocomposites decorated with folic acid conjugated chitosan as a promising biocompatible targeted theranostic system for cancer treatment.
Topics: Animals; Biocompatible Materials; Cell Death; Cell Line, Tumor; Cell Survival; Chitosan; Curcumin; Drug Liberation; Erythrocytes; Ferric Compounds; Fluorouracil; Folic Acid; Hemolysis; Humans; Magnetic Resonance Imaging; Magnetics; Metal-Organic Frameworks; Mice; Mice, Inbred BALB C; Nanocomposites; Neoplasms; NIH 3T3 Cells; Phantoms, Imaging; Protein Corona; Theranostic Nanomedicine; X-Ray Diffraction | 2019 |
Minicapsules encapsulating nanoparticles for targeting, apoptosis induction and treatment of colon cancer.
Topics: Animals; Apoptosis; Capsules; Caspase 3; Cell Line, Tumor; Cell Survival; Chitosan; Colonic Neoplasms; DNA Fragmentation; Folic Acid; Mice; Mice, Inbred C57BL; Nanoparticles; Staurosporine; Xenograft Model Antitumor Assays | 2019 |
Synthesis of
Topics: Acetates; Animals; Chelating Agents; Chitosan; Disease Models, Animal; Female; Folate Receptor 1; Folic Acid; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Mice; Nanoparticles; Ovarian Neoplasms; Polyglutamic Acid; Positron-Emission Tomography | 2019 |
Characterization, Cytotoxicity and Genotoxicity of Graphene Oxide and Folate Coupled Chitosan Nanocomposites Loading Polyprenol and Fullerene Based Nanoemulsion Against MHCC97H Cells.
Topics: Carcinoma, Hepatocellular; Chitosan; Folic Acid; Fullerenes; Graphite; Humans; Liver Neoplasms; Nanocomposites; Oxides | 2019 |
Chitosan-mediated green synthesis and folic-acid modification of CuS quantum dots for photoacoustic imaging guided photothermal therapy of tumor.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Copper; Drug Screening Assays, Antitumor; Female; Folic Acid; Mice; Optical Imaging; Particle Size; Photoacoustic Techniques; Photochemotherapy; Quantum Dots; Surface Properties | 2019 |
New approaches to tumor therapy with siRNA-decorated and chitosan-modified PLGA nanoparticles.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cancer Pain; Cell Line, Tumor; Cell Survival; Chitosan; Cyclooxygenase Inhibitors; Drug Carriers; Flurbiprofen; Folic Acid; Humans; Mice; Nanoparticles; Neoplasms; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; RNA, Small Interfering; STAT3 Transcription Factor | 2019 |
Folate-decorated, endostatin-loaded, nanoparticles for anti-proliferative chemotherapy in esophaegeal squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chitosan; Drug Liberation; Endocytosis; Endostatins; Esophageal Squamous Cell Carcinoma; Folic Acid; Humans; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Necrosis; Polyethylene Glycols; Polyethyleneimine; Tumor Burden; Xenograft Model Antitumor Assays | 2019 |
Folate-chitosan nanoparticles triggered insulin cellular uptake and improved in vivo hypoglycemic activity.
Topics: Administration, Oral; Animals; Blood Glucose; Caco-2 Cells; Chitosan; Drug Carriers; Drug Evaluation, Preclinical; Drug Stability; Folic Acid; Humans; Hypoglycemic Agents; Insulin; Male; Models, Animal; Nanoparticles; Particle Size; Rats; Toxicity Tests | 2019 |
A versatile endosome acidity-induced sheddable gene delivery system: increased tumor targeting and enhanced transfection efficiency.
Topics: Animals; Cell Death; Cell Line, Tumor; Chitosan; DNA; Endocytosis; Endosomes; Female; Folic Acid; Genetic Therapy; Green Fluorescent Proteins; Humans; Hydrogen-Ion Concentration; Mice, Inbred BALB C; Neoplasms; Nuclear Localization Signals; Particle Size; Plasmids; Polyethylene Glycols; Polyethyleneimine; Static Electricity; Transfection | 2019 |
Folic acid-conjugated chitosan-functionalized graphene oxide for highly efficient photoacoustic imaging-guided tumor-targeted photothermal therapy.
Topics: Animals; Cell Line, Tumor; Chitosan; Female; Folic Acid; Graphite; Humans; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Neoplasms; Photoacoustic Techniques; Photothermal Therapy; Theranostic Nanomedicine | 2020 |
Tailor-made ternary nanopolyplexes of thiolated trimethylated chitosan with pDNA and folate conjugated cis-aconitic amide-polyethylenimine for efficient gene delivery.
Topics: Chitosan; DNA; Drug Carriers; Folic Acid; HeLa Cells; Humans; Hydrogen-Ion Concentration; Intracellular Space; Methylation; Plasmids; Polyethyleneimine; Sulfhydryl Compounds; Transfection | 2020 |
A microfluidic platform culturing two cell lines paralleled under in-vivo like fluidic microenvironment for testing the tumor targeting of nanoparticles.
Topics: A549 Cells; Animals; Apoptosis; Cell Proliferation; Chitosan; Cholesterol; Folic Acid; HeLa Cells; Humans; Mice; Mice, Nude; Microfluidics; Nanoparticles; Neoplasms; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2020 |
UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid.
Topics: Cell Line, Tumor; Cell Survival; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Liberation; Folic Acid; Humans; Kinetics; Metal-Organic Frameworks; Nanofibers; Nanoparticles; Polyethylene Glycols; Polyurethanes; Spectrum Analysis | 2020 |
Formulation of a pH-sensitive cancer cell-targeted gene delivery system based on folate-chitosan conjugated nanoparticles.
Topics: Chitosan; DNA; Folic Acid; Gene Transfer Techniques; Humans; Hydrogen-Ion Concentration; Nanoparticles; Neoplasms | 2021 |
Folate receptor-targeted RNAi nanoparticles for silencing STAT3 in tumor-associated macrophages and tumor cells.
Topics: Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Survival; Chitosan; Folate Receptor 1; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Nanoparticles; RNA, Small Interfering; RNAi Therapeutics; STAT3 Transcription Factor; Tumor-Associated Macrophages | 2020 |
Novel β-1,3-d-glucan porous microcapsule enveloped folate-functionalized liposomes as a Trojan horse for facilitated oral tumor-targeted co-delivery of chemotherapeutic drugs and quantum dots.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Transport; Cell Survival; Chitosan; Drug Compounding; Drug Liberation; Drug Synergism; Fluorescent Dyes; Folic Acid; Gefitinib; Humans; Liposomes; Male; Mice; Mice, Nude; Mouth Neoplasms; Porosity; Proteoglycans; Quantum Dots; Rats, Sprague-Dawley; Tissue Distribution; Zinc Oxide | 2020 |
Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment.
Topics: A549 Cells; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Folic Acid; Humans; Hydrophobic and Hydrophilic Interactions; Hypoxia; MCF-7 Cells; Mice; Nanoparticles; Polyethylene Glycols | 2020 |
Design and Characterization of a Cancer-Targeted Drug Co-Delivery System Composed of Liposomes and Selenium Nanoparticles.
Topics: Chitosan; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Folic Acid; HeLa Cells; Humans; Liposomes; Nanoparticles; Neoplasms; Renal Dialysis; Selenium; Spectroscopy, Fourier Transform Infrared | 2020 |
Role of folate-conjugated glycol-chitosan nanoparticles in modulating the activated macrophages to ameliorate inflammatory arthritis: in vitro and in vivo activities.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Survival; Chitosan; Drug Liberation; Female; Folic Acid; HEK293 Cells; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Methotrexate; Mice; Nanoparticles; Rats, Wistar; RAW 264.7 Cells | 2020 |
Optically controlled hybrid metamaterial of plasmonic spiky gold inbuilt graphene sheets for bimodal imaging guided multimodal therapy.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Chitosan; Doxorubicin; Folic Acid; Gold; Graphite; Humans; Mice; Nanostructures; Neoplasms; Photochemotherapy; Photosensitizing Agents; Phototherapy; Protoporphyrins; Spectrum Analysis, Raman | 2020 |
Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacy.
Topics: Cell Line, Tumor; Chitosan; Cisplatin; Drug Delivery Systems; Flow Cytometry; Folic Acid; Humans; MCF-7 Cells; Microscopy, Fluorescence; Nanoparticles; Polymers; Spheroids, Cellular | 2020 |
Folate-induced nanostructural changes of oligochitosan nanoparticles and their fate of cellular internalization by melanoma.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chitin; Chitosan; Drug Carriers; Fluorouracil; Folic Acid; Humans; Melanoma; Melanoma, Cutaneous Malignant; Nanoparticles; Oligosaccharides; Skin Neoplasms | 2020 |
Functionalized layer-by-layer assembled film with directional 5-fluorouracil release to target colon cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Caco-2 Cells; Capsules; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Colonic Neoplasms; Drug Compounding; Fluorouracil; Folic Acid; Humans; Male; Polyesters; Rabbits; Rats; Spheroids, Cellular; Xenograft Model Antitumor Assays | 2020 |
Facile Fabrication of Nanoparticles with Dual-Targeting Ligands for Precise Hepatocellular Carcinoma Therapy
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Chitosan; Fluorouracil; Folic Acid; Hepatocytes; Human Umbilical Vein Endothelial Cells; Humans; Ligands; Liver Neoplasms; Nanoparticles; Precision Medicine; Prodrugs; Solubility | 2020 |
[Synthesis of folate modified chitosan-based nanomicelles and its
Topics: Antineoplastic Agents; Chitosan; Doxorubicin; Drug Carriers; Folic Acid; Humans; Micelles; Nanostructures; Polymers | 2020 |
Design of polysaccharidic nano-in-micro soft agglomerates as primary oral drug delivery vehicle for colon-specific targeting.
Topics: Administration, Oral; Alginates; Antimetabolites; Chitosan; Colon; Drug Delivery Systems; Drug Liberation; Fluorouracil; Folic Acid; Humans; Nanoparticles; Pectins; Vitamin B Complex | 2020 |
Evidence Supporting the Safety of Pegylated Diethylaminoethyl-Chitosan Polymer as a Nanovector for Gene Therapy Applications.
Topics: Animals; Cell Survival; Chitosan; Folic Acid; Genetic Therapy; Humans; Hydrogen-Ion Concentration; Mice; Nanoparticles; Nitric Oxide; Polyethylene Glycols; Polymers; RAW 264.7 Cells; Reactive Oxygen Species; RNA, Small Interfering; Toxicity Tests | 2020 |
A targeted and redox/pH-responsive chitosan oligosaccharide derivatives based nanohybrids for overcoming multidrug resistance of breast cancer cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Chitosan; Drug Carriers; Drug Liberation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Folic Acid; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Nanoparticles; Oxidation-Reduction; Paclitaxel; Polyethyleneimine; RNA, Small Interfering | 2021 |
Novel Cells-Based Electrochemical Sensor for Investigating the Interactions of Cancer Cells with Molecules and Screening Multitarget Anticancer Drugs.
Topics: Aniline Compounds; Antineoplastic Agents; Biosensing Techniques; Chitosan; Dimethyl Sulfoxide; Drug Evaluation, Preclinical; Electrochemical Techniques; Folic Acid; Graphite; Humans; Metal Nanoparticles; Molecular Docking Simulation; Particle Size; Platinum; Surface Properties; Tumor Cells, Cultured | 2021 |
Design of folic acid decorated virus-mimicking nanoparticles for enhanced oral insulin delivery.
Topics: Administration, Oral; Chitosan; Drug Delivery Systems; Folic Acid; Insulin; Nanoparticles; Polymers | 2021 |
Cytotoxicity Effects of Curcumin Loaded on Chitosan Alginate Nanospheres on the KMBC-10 Spheroids Cell Line.
Topics: Alginates; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Chitosan; Curcumin; Female; Fluorescence; Folic Acid; Gene Expression Regulation; Humans; Inhibitory Concentration 50; Male; Nanospheres; Particle Size; Solubility; Spectroscopy, Fourier Transform Infrared; Spheroids, Cellular | 2021 |
Synthesis of functionalized silk-coated chitosan-gold nanoparticles and microparticles for target-directed delivery of antitumor agents.
Topics: Antineoplastic Agents; Cell Survival; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fibroins; Fluorescein; Folic Acid; Gold; Green Chemistry Technology; HeLa Cells; Humans; Hydrogels; Metal Nanoparticles; Microscopy, Fluorescence; Microspheres; Molecular Weight; Particle Size; Silk; Spectroscopy, Fourier Transform Infrared; Surface Properties; Tetrazolium Salts; Thiazoles | 2021 |
Folic acid decorated chitosan-coated solid lipid nanoparticles for the oral treatment of rheumatoid arthritis.
Topics: Administration, Oral; Animals; Arthritis, Rheumatoid; Chitosan; Drug Carriers; Folic Acid; Lipids; Nanoparticles; Rats | 2021 |
Chitosan-PEG-folate-Fe(III) complexes as nanocarriers of epigallocatechin-3-gallate.
Topics: Catechin; Chitosan; Delayed-Action Preparations; Drug Compounding; Drug Stability; Ferric Compounds; Folic Acid; Nanoparticles; Particle Size; Polyethylene Glycols; Surface Properties | 2020 |
Folate-targeted Pluronic-chitosan nanocapsules loaded with IR780 for near-infrared fluorescence imaging and photothermal-photodynamic therapy of ovarian cancer.
Topics: Apoptosis; Cell Line, Tumor; Chitosan; Female; Folic Acid; Humans; Hyperthermia, Induced; Indoles; Nanocapsules; Optical Imaging; Ovarian Neoplasms; Photochemotherapy; Phototherapy | 2021 |
Optimally designed theranostic system based folic acids and chitosan as a promising mucoadhesive delivery system for encapsulating curcumin LbL nano-template against invasiveness of breast cancer.
Topics: Adhesiveness; Adsorption; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Death; Cell Shape; Chitosan; Curcumin; Drug Compounding; Drug Delivery Systems; Drug Liberation; Female; Folic Acid; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Nanoparticles; Necrosis; Neoplasm Invasiveness; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Static Electricity; Stereoisomerism; Theranostic Nanomedicine | 2021 |
Partition and stability of folic acid and caffeic acid in hollow zein particles coated with chitosan.
Topics: Antioxidants; Caffeic Acids; Calcium Phosphates; Chitosan; Drug Carriers; Drug Compounding; Drug Stability; Folic Acid; Hydrogen-Ion Concentration; Photolysis; Surface Properties; Zein | 2021 |
Chitosan-coated Zn-metal-organic framework nanocomposites for effective targeted delivery of LNA-antisense miR-224 to colon tumor: in vitro studies.
Topics: Cell Line, Tumor; Chitosan; Colonic Neoplasms; Folic Acid; Humans; Metal-Organic Frameworks; MicroRNAs; Nanocomposites; Spectroscopy, Fourier Transform Infrared; Zinc | 2022 |
A multiple environment-sensitive prodrug nanomicelle strategy based on chitosan graftomer for enhanced tumor therapy of gambogic acid.
Topics: Acrylic Resins; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chitosan; Drug Carriers; Drug Liberation; Folic Acid; Humans; Hydrogen-Ion Concentration; Male; Mice; Micelles; Neoplasms; Prodrugs; Temperature; Xanthones | 2021 |
Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
Topics: Animals; Breast Neoplasms; Cell Line; Cell Line, Tumor; Chitosan; Deoxycytidine; Female; Folic Acid; Gemcitabine; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Nanoparticles; Particle Size; Rats; Silver | 2021 |
All-Trans Retinoic Acid and Doxorubicin Delivery by Folic Acid Modified Polymeric Micelles for the Modulation of Pin1-Mediated DOX-Induced Breast Cancer Stemness and Metastasis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Chitosan; Disease Models, Animal; Doxorubicin; Drug Liberation; Drug Synergism; Female; Folic Acid; Gene Knockdown Techniques; Humans; Mice; Micelles; Nanoparticle Drug Delivery System; Neoplastic Stem Cells; NIMA-Interacting Peptidylprolyl Isomerase; Tissue Distribution; Tretinoin | 2021 |
Tailoring the proliferation of fibroblast cells by multiresponsive and thermosensitive stem cells composite F127 hydrogel containing folic acid.MgO:ZnO/chitosan hybrid microparticles for skin regeneration.
Topics: Anti-Bacterial Agents; Cell Proliferation; Chitosan; Fibroblasts; Folic Acid; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Hydrogels; Magnesium Oxide; Mesenchymal Stem Cells; Polyethylenes; Polypropylenes; Wound Healing; Zinc Oxide | 2021 |
Biosecurity Test of Conjugated Nanoparticles of Chitosan-Protoporphyrin IX-Vitamin B9 for Their Use in Photodynamic Therapy.
Topics: Biosecurity; Chitosan; Folic Acid; Nanoparticles; Photochemotherapy; Protoporphyrins | 2022 |
Effect of targeting ligand designation of self-assembly chitosan-poloxamer nanogels loaded Paclitacel on inhibiting MCF-7 cancer cell growth.
Topics: Cell Line, Tumor; Chitosan; Drug Carriers; Folic Acid; Humans; Ligands; MCF-7 Cells; Nanogels; Nanoparticles; Neoplasms; Paclitaxel; Poloxamer | 2022 |
Preparation and Characterization of Docetaxel-PLGA Nanoparticles Coated with Folic Acid-chitosan Conjugate for Cancer Treatment.
Topics: Chitosan; Docetaxel; Folic Acid; Humans; Lactic Acid; Nanoparticles; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2022 |
Unraveling the Effect of Breast Cancer Patients' Plasma on the Targeting Ability of Folic Acid-Modified Chitosan Nanoparticles.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Folic Acid; Humans; Macrophages; Nanoparticles | 2021 |
Investigating the structure of the product of graphene oxide reaction with folic acid and chitosan: density functional theory calculations.
Topics: Chitosan; Density Functional Theory; Folic Acid; Graphite | 2022 |
Synthesis of Chitosan Nanoparticles Conjugated With Protoporphyrin IX and Vitamin B9 for Their Application in Photodynamic Therapy.
Topics: Chitosan; Folic Acid; Nanoconjugates; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Protoporphyrins | 2022 |
Bioinspired synthesis of protein/polysaccharide-decorated folate as a nanocarrier of curcumin to potentiate cancer therapy.
Topics: Alginates; Animals; Chitosan; Curcumin; Folic Acid; Mice; Nanoparticles; Neoplasms | 2022 |
Folate functionalized chitosan nanoparticles as targeted delivery systems for improved anticancer efficiency of cytarabine in MCF-7 human breast cancer cell lines.
Topics: Breast Neoplasms; Cell Survival; Chitosan; Cytarabine; Drug Carriers; Drug Delivery Systems; Female; Folic Acid; Humans; MCF-7 Cells; Nanoparticles | 2022 |
Folic acid conjugated chitosan encapsulated palladium nanoclusters for NIR triggered photothermal breast cancer treatment.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Folic Acid; HEK293 Cells; Humans; Light; Nanoparticles; Palladium; Rutin; Temperature; Triple Negative Breast Neoplasms | 2022 |
Fabrication and assessment of folic acid conjugated-chitosan modified PLGA nanoparticle for delivery of alpha terpineol in colon cancer.
Topics: Animals; Antioxidants; Chitosan; Colonic Neoplasms; Cyclohexane Monoterpenes; Drug Carriers; Folic Acid; Humans; Mice; Nanoparticles; Particle Size; Vascular Endothelial Growth Factor A | 2022 |
Enhanced cellular uptake, transport and oral bioavailability of optimized folic acid-loaded chitosan nanoparticles.
Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Chitosan; Drug Carriers; Folic Acid; Humans; Nanoparticles; Particle Size; Rats | 2022 |
Hybrid Theranostic Cubosomes for Efficient NIR-Induced Photodynamic Therapy.
Topics: Chitosan; Folic Acid; Humans; Melanoma; Nanoparticles; Photochemotherapy; Precision Medicine | 2022 |
Biodegradable and biocompatible subcutaneous implants consisted of pH-sensitive mebendazole-loaded/folic acid-targeted chitosan nanoparticles for murine triple-negative breast cancer treatment.
Topics: Animals; Chitosan; Folic Acid; Humans; Hydrogen-Ion Concentration; Mebendazole; Mice; Nanoparticles; Triple Negative Breast Neoplasms | 2022 |
Different Serum, Different Protein Corona! The Impact of the Serum Source on Cellular Targeting of Folic Acid-Modified Chitosan-Based Nanoparticles.
Topics: Breast Neoplasms; Chitosan; Female; Folic Acid; Humans; Nanoparticles; Protein Corona; Proteomics; Reproducibility of Results; Serum Albumin, Bovine | 2022 |
Co-delivery of doxorubicin and CRISPR/Cas9 or RNAi-expressing plasmid by chitosan-based nanoparticle for cancer therapy.
Topics: Cell Line, Tumor; Chitosan; CRISPR-Cas Systems; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; Frontotemporal Dementia; Humans; Nanoparticles; Neoplasms; Plasmids; RNA Interference; Survivin | 2022 |
Folic Acid and Chitosan-Functionalized Gold Nanorods and Triangular Silver Nanoplates for the Delivery of Anticancer Agents.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chitosan; Docetaxel; Folic Acid; G2 Phase Cell Cycle Checkpoints; Gold; HeLa Cells; Humans; Metal Nanoparticles; Nanotubes; Paclitaxel; Silver | 2022 |
Targeting colon cancer stem cells using novel doublecortin like kinase 1 antibody functionalized folic acid conjugated hesperetin encapsulated chitosan nanoparticles.
Topics: Cell Line, Tumor; Cell Proliferation; Chitosan; Colonic Neoplasms; Doublecortin-Like Kinases; Folic Acid; Hesperidin; Humans; Intracellular Signaling Peptides and Proteins; Nanoparticles; Neoplastic Stem Cells; Protein Serine-Threonine Kinases | 2022 |
Nanofabrication of PLGA-PEG-chitosan-folic acid systems for delivery of colchicine to HT-29 cancer cells.
Topics: Antioxidants; Chitosan; Colchicine; Drug Carriers; Folic Acid; Humans; Nanoparticles; Neoplasms; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer | 2023 |
Immunomodulation of MiRNA-223-based nanoplatform for targeted therapy in retinopathy of prematurity.
Topics: Animals; Chitosan; Disease Models, Animal; Folic Acid; Humans; Immunomodulation; Infant, Newborn; Inflammation; Interleukin-6; Mice; MicroRNAs; Neovascularization, Pathologic; Oxygen; Retinopathy of Prematurity; Silicon Dioxide | 2022 |
Mitochondria-targeting folic acid-modified nanoplatform based on mesoporous carbon and a bioactive peptide for improved colorectal cancer treatment.
Topics: Carbon; Caspase 3; Cell Line, Tumor; Chitosan; Colorectal Neoplasms; Drug Delivery Systems; Folic Acid; Formaldehyde; Humans; Mitochondria; Nanoparticles; Peptides; Phloroglucinol; Tumor Suppressor Protein p53 | 2022 |
Chitosan-alginate nanoparticles of cabazitaxel: Design, dual-receptor targeting and efficacy in lung cancer model.
Topics: Alginates; Animals; Cell Line, Tumor; Chitosan; Folic Acid; Lung Neoplasms; Mice; Nanoparticles; Rats; Rats, Wistar | 2022 |
Effective uptake of folate-functionalized ethionamide-loaded hybrid system: targeting alveolar macrophages.
Topics: Biological Transport; Chitosan; Drug Carriers; Drug Delivery Systems; Ethionamide; Folic Acid; Macrophages, Alveolar; Nanoparticles; Spectroscopy, Fourier Transform Infrared | 2022 |
Folate decorated lipid chitosan hybrid nanoparticles of 5-fluorouracil for enhanced anticancer efficacy against colon cancer.
Topics: Cell Line, Tumor; Chitosan; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; Fluorouracil; Folic Acid; Humans; Lipids; Nanoparticles; Particle Size | 2022 |
Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses.
Topics: Animals; Cell Line, Tumor; Chitosan; Enhancer of Zeste Homolog 2 Protein; Folic Acid; Humans; Magnetic Iron Oxide Nanoparticles; Mice; Nanoparticles; RNA, Small Interfering; Triple Negative Breast Neoplasms; Tumor Microenvironment | 2022 |
Synthesis and Application of MOF-808 Decorated with Folic Acid-Conjugated Chitosan as a Strong Nanocarrier for the Targeted Drug Delivery of Quercetin.
Topics: Cell Survival; Chitosan; Drug Carriers; Drug Delivery Systems; Folic Acid; Nanoparticles; Quercetin | 2022 |
Enhanced encapsulation efficiency and controlled release of co-encapsulated Bacillus coagulans spores and vitamin B9 in gellan/κ-carrageenan/chitosan tri-composite hydrogel.
Topics: Bacillus coagulans; Carrageenan; Chitosan; Delayed-Action Preparations; Folic Acid; Hydrogels; Probiotics; Spores, Bacterial | 2023 |
Tumor Targeting and pH-Sensitive Inclusion Complex Based on HP-β-CD as a Potential Carrier for Paclitaxel: Fabrication, Molecular Docking, and Characterization.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chitosan; Drug Carriers; Excipients; Folic Acid; Humans; Hydrogen-Ion Concentration; Molecular Docking Simulation; Neoplasms; Paclitaxel | 2023 |
Synthesis, characterization and in vitro digestion of folate conjugated chitosan-loaded proanthocyanidins nanoparticles.
Topics: Chitosan; Digestion; Drug Carriers; Folic Acid; Nanoparticles; Proanthocyanidins; Spectroscopy, Fourier Transform Infrared | 2023 |
PEGylated Lecithin-Chitosan-Folic Acid Nanoparticles as Nanocarriers of Allicin for In Vitro Controlled Release and Anticancer Effects.
Topics: Anti-Bacterial Agents; Antioxidants; Chitosan; Delayed-Action Preparations; Drug Carriers; Folic Acid; Lecithins; Nanoparticles; Polyethylene Glycols | 2023 |
Fabrication of biocompatible magnetic maltose/MIL-88 metal-organic frameworks decorated with folic acid-chitosan for targeted and pH-responsive controlled release of doxorubicin.
Topics: Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Hydrogen-Ion Concentration; Magnetic Phenomena; Maltose; Metal-Organic Frameworks | 2023 |
Conjugation of folic acid with poly (NVCL-co-PEGMA)-grafted chitosan as a new doxorubicin delivery system.
Topics: Breast Neoplasms; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Folic Acid; Humans; Hydrogen-Ion Concentration | 2023 |
Folic Acid-Chitosan Oligosaccharide Conjugates Decorated Nanodiamond as Potential Carriers for the Oral Delivery of Doxorubicin.
Topics: Animals; Caco-2 Cells; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Nanodiamonds; Oligosaccharides; Rats | 2023 |
Lawsone encapsulated polylactic-co-glycolic acid nanoparticles modified with chitosan-folic acid successfully inhibited cell growth and triggered apoptosis in Panc-1 cancer cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Chitosan; Drug Carriers; Folic Acid; Glycols; Lactic Acid; Nanoparticles; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2023 |
Smart chitosan-PLGA nanocarriers functionalized with surface folic acid ligands against lung cancer cells.
Topics: Chitosan; Drug Carriers; Folic Acid; Glycols; Humans; Ligands; Lung Neoplasms; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer | 2023 |
Effect of folic acid-linked chitosan-coated PLGA-based curcumin nanoparticles on the redox system of glioblastoma cancer cells.
Topics: Antioxidants; Catalase; Chitosan; Curcumin; Folic Acid; Glioblastoma; Glutaredoxins; Nanoparticles; Oxidation-Reduction; Polylactic Acid-Polyglycolic Acid Copolymer; Reactive Oxygen Species; Superoxide Dismutase; Thioredoxins | 2023 |
Preparation and Characterization of Allicin-Loaded Solid Lipid Nanoparticles Surface-Functionalized with Folic Acid-Bonded Chitosan:
Topics: Antioxidants; Chitosan; Folic Acid; Humans; Nanoparticles | 2023 |
Folic acid-chitosan functionalized polymeric nanocarriers to treat colon cancer.
Topics: Animals; Caco-2 Cells; Chitosan; Colonic Neoplasms; Drug Carriers; Folic Acid; Humans; Nanoparticles; Polymers; Rats | 2023 |
The folate-linked chitosan-coated Kaempferol/HSA nano-transporters (FCKH-NTs) as the selective apoptotic inducer in human MCF-7 breast cancer cell line.
Topics: Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Chitosan; Female; Folic Acid; Humans; Kaempferols; MCF-7 Cells; Serum Albumin, Human | 2023 |
Oral delivery of pectin-chitosan hydrogels entrapping macrophage-targeted curcumin-loaded liposomes for the treatment of ulcerative colitis.
Topics: Animals; Chitosan; Colitis, Ulcerative; Colon; Curcumin; Cyclooxygenase Inhibitors; Folic Acid; Hydrogels; Liposomes; Macrophages; Mice; Nanoparticles; Pectins | 2023 |
Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade.
Topics: Adenosine; Caffeine; Chitosan; Folic Acid; Humans; Immunotherapy; Methotrexate; Molecular Docking Simulation; Nanoparticles; Neoplasms; Receptor, Adenosine A2A; Tumor Microenvironment | 2023 |